Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	deacetylase activity	HDAC9 NDST1 HDAC4 NDST2 HDAC1 HDAC2	8.03e-08	40	110	6	GO:0019213
GeneOntologyMolecularFunction	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides	HDAC9 NDST1 HDAC4 NDST2 VNN1 HDAC1 HDAC2	3.16e-07	81	110	7	GO:0016811
GeneOntologyMolecularFunction	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds	HDAC9 NDST1 HDAC4 NDST2 VNN1 CD101 HDAC1 HDAC2	1.47e-06	146	110	8	GO:0016810
GeneOntologyMolecularFunction	histone deacetylase activity	HDAC9 HDAC4 HDAC1 HDAC2	8.51e-06	24	110	4	GO:0004407
GeneOntologyMolecularFunction	protein lysine deacetylase activity	HDAC9 HDAC4 HDAC1 HDAC2	1.01e-05	25	110	4	GO:0033558
GeneOntologyMolecularFunction	MHC class II receptor activity	HLA-DOA HLA-DQA1 HLA-DQA2	2.60e-05	11	110	3	GO:0032395
GeneOntologyMolecularFunction	Krueppel-associated box domain binding	HDAC1 HDAC2	8.99e-05	3	110	2	GO:0035851
GeneOntologyMolecularFunction	heparan sulfate N-deacetylase activity	NDST1 NDST2	8.99e-05	3	110	2	GO:0102140
GeneOntologyMolecularFunction	histone H4K16 deacetylase activity, hydrolytic mechanism	HDAC9 HDAC2	1.79e-04	4	110	2	GO:0034739
GeneOntologyMolecularFunction	histone H4K deacetylase activity	HDAC9 HDAC2	1.79e-04	4	110	2	GO:0141051
GeneOntologyMolecularFunction	[heparan sulfate]-glucosamine N-sulfotransferase activity	NDST1 NDST2	1.79e-04	4	110	2	GO:0015016
GeneOntologyMolecularFunction	N-acetylglucosamine deacetylase activity	NDST1 NDST2	1.79e-04	4	110	2	GO:0050119
GeneOntologyMolecularFunction	protein decrotonylase activity	HDAC1 HDAC2	2.97e-04	5	110	2	GO:0160008
GeneOntologyMolecularFunction	histone decrotonylase activity	HDAC1 HDAC2	2.97e-04	5	110	2	GO:0160009
GeneOntologyMolecularFunction	immune receptor activity	EPOR HLA-DOA HLA-DQA1 HLA-DQA2 KIR2DL4 PRLR	3.06e-04	165	110	6	GO:0140375
GeneOntologyMolecularFunction	MHC class II protein complex binding	HLA-DOA HLA-DQA1 HLA-DQA2	4.32e-04	27	110	3	GO:0023026
GeneOntologyMolecularFunction	peptidase activity	RHBDD1 PSMB11 ADAM8 MEP1A BMP1 MALT1 MINDY3 PRCP CFAP44 CTSD TMPRSS11A	9.68e-04	654	110	11	GO:0008233
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SOX9 HIVEP2 HDAC4 RBMXL1 ZNF460 CPHXL2 ZNF395 NR4A1 SP8 HOXB1 JUNB PAX8 RBMX TBR1 HDAC1 HDAC2	1.27e-03	1244	110	16	GO:0000978
GeneOntologyMolecularFunction	MHC protein complex binding	HLA-DOA HLA-DQA1 HLA-DQA2	1.49e-03	41	110	3	GO:0023023
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SOX9 HIVEP2 HDAC4 RBMXL1 ZNF460 CPHXL2 ZNF395 NR4A1 SP8 HOXB1 JUNB PAX8 RBMX TBR1 HDAC1 HDAC2	1.59e-03	1271	110	16	GO:0000987
GeneOntologyMolecularFunction	peptide antigen binding	HLA-DOA HLA-DQA1 HLA-DQA2	2.49e-03	49	110	3	GO:0042605
GeneOntologyMolecularFunction	chromatin binding	SOX9 HDAC4 RBMXL1 MBD3 MLH3 KLHDC3 RBMX CTNNB1 TBR1 HDAC1 HDAC2	2.54e-03	739	110	11	GO:0003682
GeneOntologyMolecularFunction	endopeptidase activity	RHBDD1 PSMB11 ADAM8 MEP1A BMP1 MALT1 CTSD TMPRSS11A	2.62e-03	430	110	8	GO:0004175
GeneOntologyMolecularFunction	heparan sulfate sulfotransferase activity	NDST1 NDST2	3.01e-03	15	110	2	GO:0034483
GeneOntologyBiologicalProcess	fungiform papilla formation	CTNNB1 HDAC1 HDAC2	5.88e-07	4	110	3	GO:0061198
GeneOntologyBiologicalProcess	macromolecule deacylation	HDAC9 NDST1 HDAC4 CPT1C HDAC1 HDAC2	1.06e-06	63	110	6	GO:0098732
GeneOntologyBiologicalProcess	positive regulation of morphogenesis of an epithelium	SOX9 ITGAX PAX8 MMRN2 CTNNB1	2.86e-06	42	110	5	GO:1905332
GeneOntologyBiologicalProcess	fungiform papilla morphogenesis	CTNNB1 HDAC1 HDAC2	2.92e-06	6	110	3	GO:0061197
GeneOntologyBiologicalProcess	hair follicle placode formation	CTNNB1 HDAC1 HDAC2	2.92e-06	6	110	3	GO:0060789
GeneOntologyBiologicalProcess	regulation of morphogenesis of an epithelium	SOX9 ITGAX PAX8 BTBD7 MMRN2 CTNNB1	3.24e-06	76	110	6	GO:1905330
GeneOntologyBiologicalProcess	protein deacetylation	HDAC9 NDST1 HDAC4 HDAC1 HDAC2	5.05e-06	47	110	5	GO:0006476
GeneOntologyBiologicalProcess	fungiform papilla development	CTNNB1 HDAC1 HDAC2	5.09e-06	7	110	3	GO:0061196
GeneOntologyBiologicalProcess	positive regulation of cell differentiation	SOX9 ZNF703 MAP1B HLA-DQA1 HLA-DQA2 LAMA2 LAMC1 ADAM8 CDKL5 MALT1 JUNB PAX8 VNN1 RIN2 CD101 CTNNB1 GOLGA4 HDAC1 HDAC2	8.90e-06	1141	110	19	GO:0045597
GeneOntologyBiologicalProcess	protein deacylation	HDAC9 NDST1 HDAC4 HDAC1 HDAC2	1.44e-05	58	110	5	GO:0035601
GeneOntologyBiologicalProcess	regulation of cell development	HDAC9 HDAC4 MAP1B HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 SPART ADAM8 CDKL5 MALT1 JUNB VNN1 CD101 CTNNB1 GOLGA4 HDAC1 HDAC2	1.88e-05	1095	110	18	GO:0060284
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class II	HLA-DOA HLA-DQA1 HLA-DQA2 CTSD	2.45e-05	32	110	4	GO:0019886
GeneOntologyBiologicalProcess	positive regulation of male mating behavior	HDAC4 HDAC2	2.82e-05	2	110	2	GO:1902437
GeneOntologyBiologicalProcess	regulation of T cell differentiation	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 ADAM8 MALT1 JUNB VNN1	2.88e-05	226	110	8	GO:0045580
GeneOntologyBiologicalProcess	lymphocyte differentiation	HDAC9 HDAC4 HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 PSMB11 ADAM8 MALT1 JUNB VNN1 CTNNB1	2.98e-05	537	110	12	GO:0030098
GeneOntologyBiologicalProcess	tongue morphogenesis	CTNNB1 HDAC1 HDAC2	3.14e-05	12	110	3	GO:0043587
GeneOntologyBiologicalProcess	regulation of cell adhesion	SOX9 ZNF703 HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 LAMA2 MFSD2B LAMC1 PTPRU ADAM8 RCC2 MALT1 VNN1 RIN2 PRLR	3.22e-05	927	110	16	GO:0030155
GeneOntologyBiologicalProcess	T cell differentiation	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 PSMB11 ADAM8 MALT1 JUNB VNN1 CTNNB1	3.82e-05	382	110	10	GO:0030217
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class II	HLA-DOA HLA-DQA1 HLA-DQA2 CTSD	3.95e-05	36	110	4	GO:0002495
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide or polysaccharide antigen via MHC class II	HLA-DOA HLA-DQA1 HLA-DQA2 CTSD	4.92e-05	38	110	4	GO:0002504
GeneOntologyBiologicalProcess	cell fate specification	SOX9 MBD3 CTNNB1 TBR1 HDAC1 HDAC2	5.14e-05	123	110	6	GO:0001708
GeneOntologyBiologicalProcess	regulation of locomotion	SOX9 HDAC9 ZNF703 HDAC4 PRR5 LAMA2 PTPRU ADAM8 ITGAX RCC2 SRPX2 CATSPER1 PRCP RIN2 SYNE2 MMRN2 TBR1 HDAC1 HDAC2	7.11e-05	1327	110	19	GO:0040012
GeneOntologyBiologicalProcess	ectodermal placode morphogenesis	CTNNB1 HDAC1 HDAC2	7.86e-05	16	110	3	GO:0071697
GeneOntologyBiologicalProcess	MHC class II protein complex assembly	HLA-DOA HLA-DQA1 HLA-DQA2	7.86e-05	16	110	3	GO:0002399
GeneOntologyBiologicalProcess	ectodermal placode formation	CTNNB1 HDAC1 HDAC2	7.86e-05	16	110	3	GO:0060788
GeneOntologyBiologicalProcess	peptide antigen assembly with MHC class II protein complex	HLA-DOA HLA-DQA1 HLA-DQA2	7.86e-05	16	110	3	GO:0002503
GeneOntologyBiologicalProcess	regulation of male mating behavior	HDAC4 HDAC2	8.43e-05	3	110	2	GO:1902435
GeneOntologyBiologicalProcess	regulation of lymphocyte differentiation	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 ADAM8 MALT1 JUNB VNN1	9.08e-05	266	110	8	GO:0045619
GeneOntologyBiologicalProcess	regulation of leukocyte differentiation	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 ADAM8 MALT1 JUNB VNN1 CD101 CTNNB1	1.00e-04	429	110	10	GO:1902105
GeneOntologyBiologicalProcess	positive regulation of cell development	MAP1B HLA-DQA1 HLA-DQA2 ADAM8 CDKL5 MALT1 VNN1 CD101 CTNNB1 GOLGA4 HDAC1 HDAC2	1.07e-04	614	110	12	GO:0010720
GeneOntologyBiologicalProcess	ectodermal placode development	CTNNB1 HDAC1 HDAC2	1.14e-04	18	110	3	GO:0071696
GeneOntologyBiologicalProcess	renal vesicle morphogenesis	SOX9 PAX8 CTNNB1	1.14e-04	18	110	3	GO:0072077
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen	HLA-DOA HLA-DQA1 HLA-DQA2 CTSD	1.24e-04	48	110	4	GO:0002478
GeneOntologyBiologicalProcess	renal vesicle development	SOX9 PAX8 CTNNB1	1.34e-04	19	110	3	GO:0072087
GeneOntologyBiologicalProcess	regulation of cell motility	SOX9 HDAC9 ZNF703 HDAC4 PRR5 LAMA2 PTPRU ADAM8 ITGAX RCC2 SRPX2 CATSPER1 PRCP RIN2 SYNE2 MMRN2 HDAC1 HDAC2	1.42e-04	1280	110	18	GO:2000145
GeneOntologyBiologicalProcess	mononuclear cell differentiation	HDAC9 HDAC4 HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 PSMB11 ADAM8 MALT1 JUNB VNN1 CTNNB1	1.58e-04	640	110	12	GO:1903131
GeneOntologyBiologicalProcess	metanephric nephron tubule formation	SOX9 PAX8	1.68e-04	4	110	2	GO:0072289
GeneOntologyBiologicalProcess	negative regulation of canonical Wnt signaling pathway	SOX9 PTPRU CTNNB1 CTNND1 HDAC1 HDAC2	1.78e-04	154	110	6	GO:0090090
GeneOntologyBiologicalProcess	MHC protein complex assembly	HLA-DOA HLA-DQA1 HLA-DQA2	1.83e-04	21	110	3	GO:0002396
GeneOntologyBiologicalProcess	peptide antigen assembly with MHC protein complex	HLA-DOA HLA-DQA1 HLA-DQA2	1.83e-04	21	110	3	GO:0002501
GeneOntologyBiologicalProcess	cell-cell adhesion	SOX9 ZNF703 HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 MFSD2B PTPRU ADAM8 ITGAX MALT1 SRPX2 VNN1 CTNNB1 CTNND1 PCDH1	1.87e-04	1077	110	16	GO:0098609
GeneOntologyBiologicalProcess	lymphocyte activation	HDAC9 HDAC4 HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 PSMB11 SLC39A10 ADAM8 ITGAX MALT1 JUNB VNN1 CTNNB1 PRLR	2.10e-04	976	110	15	GO:0046649
GeneOntologyBiologicalProcess	regulation of cell migration	SOX9 HDAC9 ZNF703 HDAC4 PRR5 LAMA2 PTPRU ADAM8 ITGAX RCC2 SRPX2 PRCP RIN2 SYNE2 MMRN2 HDAC1 HDAC2	2.26e-04	1211	110	17	GO:0030334
GeneOntologyBiologicalProcess	metanephric nephron morphogenesis	SOX9 PAX8 CTNNB1	2.42e-04	23	110	3	GO:0072273
GeneOntologyBiologicalProcess	nephron tubule formation	SOX9 PAX8 CTNNB1	2.42e-04	23	110	3	GO:0072079
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous antigen	HLA-DOA HLA-DQA1 HLA-DQA2 CTSD	2.60e-04	58	110	4	GO:0019884
GeneOntologyBiologicalProcess	positive regulation of cell adhesion	HLA-DOA HLA-DQA1 HLA-DQA2 LAMA2 MFSD2B LAMC1 PTPRU ADAM8 MALT1 VNN1 RIN2	2.69e-04	579	110	11	GO:0045785
GeneOntologyBiologicalProcess	leukocyte differentiation	HDAC9 HDAC4 HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 PSMB11 ADAM8 MALT1 JUNB VNN1 CD101 CTNNB1	2.95e-04	789	110	13	GO:0002521
GeneOntologyBiologicalProcess	negative regulation of stem cell population maintenance	PAX8 HDAC1 HDAC2	3.51e-04	26	110	3	GO:1902455
GeneOntologyBiologicalProcess	positive regulation of epithelial to mesenchymal transition	ZNF703 ADAM8 CTNNB1 HDAC2	3.58e-04	63	110	4	GO:0010718
GeneOntologyBiologicalProcess	animal organ morphogenesis	SOX9 EPOR NDST1 LAMA2 LAMC1 TECTA ITGAX BMP1 HOXB1 PAX8 BTBD7 CTNNB1 CTNND1 TBR1 CTSD HDAC1 HDAC2	3.90e-04	1269	110	17	GO:0009887
GeneOntologyBiologicalProcess	tongue development	CTNNB1 HDAC1 HDAC2	3.93e-04	27	110	3	GO:0043586
GeneOntologyBiologicalProcess	regulation of morphogenesis of a branching structure	SOX9 PAX8 BTBD7 CTNNB1	4.04e-04	65	110	4	GO:0060688
GeneOntologyBiologicalProcess	metanephric tubule formation	SOX9 PAX8	4.17e-04	6	110	2	GO:0072174
GeneOntologyBiologicalProcess	peptidyl-lysine deacetylation	HDAC9 HDAC4	4.17e-04	6	110	2	GO:0034983
GeneOntologyBiologicalProcess	regulation of lymphocyte activation	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 SLC39A10 ADAM8 MALT1 JUNB VNN1 CTNNB1 PRLR	4.41e-04	614	110	11	GO:0051249
GeneOntologyBiologicalProcess	metanephros morphogenesis	SOX9 PAX8 CTNNB1	4.87e-04	29	110	3	GO:0003338
GeneOntologyBiologicalProcess	regulation of cell fate specification	MBD3 HDAC1 HDAC2	4.87e-04	29	110	3	GO:0042659
GeneOntologyBiologicalProcess	hair follicle development	SOX9 LAMC1 CTNNB1 HDAC1 HDAC2	5.16e-04	123	110	5	GO:0001942
GeneOntologyBiologicalProcess	molting cycle process	SOX9 LAMC1 CTNNB1 HDAC1 HDAC2	5.76e-04	126	110	5	GO:0022404
GeneOntologyBiologicalProcess	hair cycle process	SOX9 LAMC1 CTNNB1 HDAC1 HDAC2	5.76e-04	126	110	5	GO:0022405
GeneOntologyBiologicalProcess	regulation of branching involved in lung morphogenesis	SOX9 CTNNB1	5.82e-04	7	110	2	GO:0061046
GeneOntologyBiologicalProcess	metanephric nephron tubule morphogenesis	SOX9 PAX8	5.82e-04	7	110	2	GO:0072282
GeneOntologyBiologicalProcess	regulation of skeletal muscle fiber differentiation	HDAC9 HDAC4	5.82e-04	7	110	2	GO:1902809
GeneOntologyBiologicalProcess	negative regulation of miRNA transcription	SOX9 HDAC4 HDAC2	5.95e-04	31	110	3	GO:1902894
GeneOntologyBiologicalProcess	positive regulation of protein processing	RHBDD1 ADAM8 CTNND1	5.95e-04	31	110	3	GO:0010954
GeneOntologyBiologicalProcess	negative regulation of Wnt signaling pathway	SOX9 PTPRU CTNNB1 CTNND1 HDAC1 HDAC2	6.27e-04	195	110	6	GO:0030178
GeneOntologyBiologicalProcess	regulation of hemopoiesis	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 ADAM8 MALT1 JUNB VNN1 CD101 CTNNB1	6.28e-04	540	110	10	GO:1903706
GeneOntologyBiologicalProcess	blood vessel endothelial cell migration	HDAC9 NR4A1 ADAM8 SRPX2 PRCP MMRN2	6.97e-04	199	110	6	GO:0043534
GeneOntologyBiologicalProcess	regulation of cell activation	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 MFSD2B SLC39A10 ADAM8 MALT1 JUNB VNN1 CTNNB1 PRLR	7.09e-04	756	110	12	GO:0050865
GeneOntologyBiologicalProcess	positive regulation of protein maturation	RHBDD1 ADAM8 CTNND1	7.17e-04	33	110	3	GO:1903319
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen	HLA-DOA HLA-DQA1 HLA-DQA2 CTSD	7.31e-04	76	110	4	GO:0048002
GeneOntologyBiologicalProcess	heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process	NDST1 NDST2	7.73e-04	8	110	2	GO:0015014
GeneOntologyBiologicalProcess	renal vesicle formation	SOX9 CTNNB1	7.73e-04	8	110	2	GO:0072033
GeneOntologyBiologicalProcess	epithelial to mesenchymal transition	SOX9 ZNF703 SLC39A10 ADAM8 CTNNB1 HDAC2	7.74e-04	203	110	6	GO:0001837
GeneOntologyBiologicalProcess	regulation of T cell activation	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 ADAM8 MALT1 JUNB VNN1 CTNNB1	7.78e-04	458	110	9	GO:0050863
GeneOntologyBiologicalProcess	negative regulation of miRNA metabolic process	SOX9 HDAC4 HDAC2	7.83e-04	34	110	3	GO:2000629
GeneOntologyBiologicalProcess	urogenital system development	SOX9 PAX8 CTNNB1 PRLR	8.46e-04	79	110	4	GO:0001655
GeneOntologyBiologicalProcess	regulation of canonical Wnt signaling pathway	SOX9 ZNF703 PTPRU CTNNB1 CTNND1 HDAC1 HDAC2	8.46e-04	285	110	7	GO:0060828
GeneOntologyBiologicalProcess	heparan sulfate proteoglycan biosynthetic process	NDST1 NDST2 CTNNB1	8.53e-04	35	110	3	GO:0015012
GeneOntologyBiologicalProcess	regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	PAX8 CTNNB1	9.90e-04	9	110	2	GO:0003339
GeneOntologyBiologicalProcess	positive regulation of T cell differentiation	HLA-DQA1 HLA-DQA2 ADAM8 MALT1 VNN1	1.05e-03	144	110	5	GO:0045582
GeneOntologyBiologicalProcess	positive regulation of lymphocyte activation	HLA-DOA HLA-DQA1 HLA-DQA2 SLC39A10 ADAM8 MALT1 VNN1 PRLR	1.07e-03	385	110	8	GO:0051251
GeneOntologyBiologicalProcess	regulation of cell-cell adhesion	ZNF703 HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 MFSD2B PTPRU ADAM8 MALT1 VNN1	1.08e-03	580	110	10	GO:0022407
GeneOntologyBiologicalProcess	metanephric nephron development	SOX9 PAX8 CTNNB1	1.09e-03	38	110	3	GO:0072210
GeneOntologyBiologicalProcess	positive regulation of cell-cell adhesion	HLA-DOA HLA-DQA1 HLA-DQA2 MFSD2B PTPRU ADAM8 MALT1 VNN1	1.15e-03	389	110	8	GO:0022409
GeneOntologyBiologicalProcess	regulation of leukocyte activation	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 SLC39A10 ADAM8 MALT1 JUNB VNN1 CTNNB1 PRLR	1.20e-03	694	110	11	GO:0002694
GeneOntologyBiologicalProcess	metanephric tubule morphogenesis	SOX9 PAX8	1.23e-03	10	110	2	GO:0072173
GeneOntologyBiologicalProcess	molting cycle	SOX9 LAMC1 CTNNB1 HDAC1 HDAC2	1.26e-03	150	110	5	GO:0042303
GeneOntologyBiologicalProcess	hair cycle	SOX9 LAMC1 CTNNB1 HDAC1 HDAC2	1.26e-03	150	110	5	GO:0042633
GeneOntologyBiologicalProcess	response to amphetamine	HDAC9 NR4A1 HDAC2	1.26e-03	40	110	3	GO:0001975
GeneOntologyBiologicalProcess	T cell activation	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 PSMB11 ADAM8 ITGAX MALT1 JUNB VNN1 CTNNB1	1.30e-03	701	110	11	GO:0042110
GeneOntologyBiologicalProcess	blood vessel development	HDAC9 EPOR NDST1 NR4A1 ADAM8 ITGAX JUNB SRPX2 PRCP LOXL1 RIN2 MMRN2 CTNNB1	1.35e-03	929	110	13	GO:0001568
GeneOntologyBiologicalProcess	specification of animal organ identity	PAX8 CTNNB1 TBR1	1.36e-03	41	110	3	GO:0010092
GeneOntologyBiologicalProcess	epithelial tube branching involved in lung morphogenesis	SOX9 CTNNB1 CTSD	1.36e-03	41	110	3	GO:0060441
GeneOntologyBiologicalProcess	regulation of basement membrane organization	LAMA2 LAMC1	1.50e-03	11	110	2	GO:0110011
GeneOntologyBiologicalProcess	heparin biosynthetic process	NDST1 NDST2	1.50e-03	11	110	2	GO:0030210
GeneOntologyBiologicalProcess	leukocyte activation	HDAC9 HDAC4 HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 PSMB11 SLC39A10 ADAM8 ITGAX MALT1 JUNB VNN1 CTNNB1 PRLR	1.57e-03	1186	110	15	GO:0045321
GeneOntologyBiologicalProcess	cell-substrate adhesion	LAMC1 TECTA AKIP1 ADAM8 ITGAX RCC2 RIN2 CTNNB1	1.60e-03	410	110	8	GO:0031589
GeneOntologyBiologicalProcess	circulatory system development	SOX9 HDAC9 EPOR NDST1 NR4A1 ADAM8 ITGAX MBD3 JUNB SRPX2 PAX8 PRCP LOXL1 RIN2 MMRN2 CTNNB1 HDAC2	1.61e-03	1442	110	17	GO:0072359
GeneOntologyCellularComponent	histone deacetylase complex	HDAC9 HDAC4 MBD3 HDAC1 HDAC2	8.28e-05	85	109	5	GO:0000118
GeneOntologyCellularComponent	CHD-type complex	MBD3 HDAC1 HDAC2	8.89e-05	17	109	3	GO:0090545
GeneOntologyCellularComponent	NuRD complex	MBD3 HDAC1 HDAC2	8.89e-05	17	109	3	GO:0016581
GeneOntologyCellularComponent	MHC class II protein complex	HLA-DOA HLA-DQA1 HLA-DQA2	8.89e-05	17	109	3	GO:0042613
GeneOntologyCellularComponent	protein complex involved in cell-matrix adhesion	LAMA2 LAMC1 MMRN2	8.89e-05	17	109	3	GO:0098637
GeneOntologyCellularComponent	supraspliceosomal complex	RBMXL1 RBMX	1.61e-04	4	109	2	GO:0044530
GeneOntologyCellularComponent	protein complex involved in cell adhesion	LAMA2 LAMC1 ITGAX MMRN2	2.55e-04	59	109	4	GO:0098636
GeneOntologyCellularComponent	transcription regulator complex	SOX9 HDAC9 HIVEP2 HDAC4 NR4A1 MBD3 JUNB PAX8 CTNNB1 HDAC1 HDAC2	2.83e-04	596	109	11	GO:0005667
GeneOntologyCellularComponent	MHC protein complex	HLA-DOA HLA-DQA1 HLA-DQA2	3.29e-04	26	109	3	GO:0042611
GeneOntologyCellularComponent	transcription repressor complex	HDAC4 CTNNB1 HDAC1 HDAC2	1.12e-03	87	109	4	GO:0017053
GeneOntologyCellularComponent	flotillin complex	CTNNB1 CTNND1	1.18e-03	10	109	2	GO:0016600
Domain	Hist_deacetyl	HDAC9 HDAC4 HDAC1 HDAC2	3.38e-07	11	108	4	PF00850
Domain	-	HDAC9 HDAC4 HDAC1 HDAC2	3.38e-07	11	108	4	3.40.800.20
Domain	His_deacetylse_dom	HDAC9 HDAC4 HDAC1 HDAC2	3.38e-07	11	108	4	IPR023801
Domain	His_deacetylse	HDAC9 HDAC4 HDAC1 HDAC2	3.38e-07	11	108	4	IPR000286
Domain	C1-set_C	HLA-DOA HLA-DQA1 HLA-DQA2	1.86e-06	5	108	3	PF16196
Domain	MHC_II_alpha	HLA-DOA HLA-DQA1 HLA-DQA2	1.86e-06	5	108	3	SM00920
Domain	C1-set_C	HLA-DOA HLA-DQA1 HLA-DQA2	1.86e-06	5	108	3	IPR032431
Domain	MHC_II_alpha	HLA-DOA HLA-DQA1 HLA-DQA2	3.71e-06	6	108	3	PF00993
Domain	MHC_II_a_N	HLA-DOA HLA-DQA1 HLA-DQA2	6.47e-06	7	108	3	IPR001003
Domain	MHC_II_a/b_N	HLA-DOA HLA-DQA1 HLA-DQA2	6.53e-05	14	108	3	IPR014745
Domain	-	HLA-DOA HLA-DQA1 HLA-DQA2	6.53e-05	14	108	3	3.10.320.10
Domain	HDAC4_Gln	HDAC9 HDAC4	9.90e-05	3	108	2	PF12203
Domain	Hist_deacetylase_Gln_rich_N	HDAC9 HDAC4	9.90e-05	3	108	2	IPR024643
Domain	His_deacetylse_1	HDAC1 HDAC2	1.97e-04	4	108	2	IPR003084
Domain	Heparan_SO4_deacetylase	NDST1 NDST2	1.97e-04	4	108	2	IPR021930
Domain	HEMATOPO_REC_L_F1	EPOR PRLR	1.97e-04	4	108	2	PS01352
Domain	Long_hematopoietin_rcpt_CS	EPOR PRLR	1.97e-04	4	108	2	IPR003528
Domain	HSNSD	NDST1 NDST2	1.97e-04	4	108	2	PF12062
Domain	Histone_deAcase_II_euk	HDAC9 HDAC4	1.97e-04	4	108	2	IPR017320
Domain	RRM_1	RBMXL1 RBMX ELAVL3	3.06e-04	23	108	3	SM00361
Domain	RRM_dom_euk	RBMXL1 RBMX ELAVL3	3.06e-04	23	108	3	IPR003954
Domain	Growth/epo_recpt_lig-bind	EPOR PRLR	3.28e-04	5	108	2	IPR015152
Domain	EpoR_lig-bind	EPOR PRLR	3.28e-04	5	108	2	PF09067
Domain	Peptidase_M12A	MEP1A BMP1	4.89e-04	6	108	2	IPR001506
Domain	Astacin	MEP1A BMP1	4.89e-04	6	108	2	PF01400
Domain	RBM1CTR	RBMXL1 RBMX	9.07e-04	8	108	2	PF08081
Domain	RBM1CTR	RBMXL1 RBMX	9.07e-04	8	108	2	IPR012604
Domain	LAMININ_IVA	LAMA2 LAMC1	9.07e-04	8	108	2	PS51115
Domain	Laminin_B	LAMA2 LAMC1	9.07e-04	8	108	2	PF00052
Domain	LamB	LAMA2 LAMC1	9.07e-04	8	108	2	SM00281
Domain	Laminin_IV	LAMA2 LAMC1	9.07e-04	8	108	2	IPR000034
Domain	MHC_I/II-like_Ag-recog	HLA-DOA HLA-DQA1 HLA-DQA2	1.37e-03	38	108	3	IPR011162
Domain	EGF	LAMA2 LAMC1 TECTA ADAM8 MEP1A BMP1	2.45e-03	235	108	6	SM00181
Domain	Kelch_2	KLHL36 KLHDC3	2.48e-03	13	108	2	IPR011498
Domain	Kelch_2	KLHL36 KLHDC3	2.48e-03	13	108	2	PF07646
Domain	MORN	RSPH1 MORN5	2.88e-03	14	108	2	SM00698
Domain	EGF-like_dom	LAMA2 LAMC1 TECTA ADAM8 MEP1A BMP1	3.26e-03	249	108	6	IPR000742
Domain	MORN	RSPH1 MORN5	3.31e-03	15	108	2	IPR003409
Domain	MORN	RSPH1 MORN5	3.31e-03	15	108	2	PF02493
Domain	C1-set	HLA-DOA HLA-DQA1 HLA-DQA2	3.76e-03	54	108	3	PF07654
Domain	MAM_1	PTPRU MEP1A	3.77e-03	16	108	2	PS00740
Domain	Laminin_N	LAMA2 LAMC1	3.77e-03	16	108	2	IPR008211
Domain	LamNT	LAMA2 LAMC1	3.77e-03	16	108	2	SM00136
Domain	LAMININ_NTER	LAMA2 LAMC1	3.77e-03	16	108	2	PS51117
Domain	Laminin_N	LAMA2 LAMC1	3.77e-03	16	108	2	PF00055
Domain	IGc1	HLA-DOA HLA-DQA1 HLA-DQA2	4.17e-03	56	108	3	SM00407
Domain	MAM	PTPRU MEP1A	4.26e-03	17	108	2	SM00137
Domain	Ig/MHC_CS	HLA-DOA HLA-DQA1 HLA-DQA2	4.61e-03	58	108	3	IPR003006
Domain	Ig_C1-set	HLA-DOA HLA-DQA1 HLA-DQA2	4.61e-03	58	108	3	IPR003597
Domain	MAM	PTPRU MEP1A	4.77e-03	18	108	2	PF00629
Domain	MAM_dom	PTPRU MEP1A	4.77e-03	18	108	2	IPR000998
Domain	MAM_2	PTPRU MEP1A	4.77e-03	18	108	2	PS50060
Domain	-	EPOR LRFN1 HLA-DOA HLA-DQA1 HLA-DQA2 PTPRU MALT1 CD101 KIR2DL4 PRLR	5.06e-03	663	108	10	2.60.40.10
Domain	IG_MHC	HLA-DOA HLA-DQA1 HLA-DQA2	5.07e-03	60	108	3	PS00290
Domain	BACK	BTBD2 KLHL36 BTBD7	5.07e-03	60	108	3	SM00875
Domain	BACK	BTBD2 KLHL36 BTBD7	5.31e-03	61	108	3	IPR011705
Domain	BACK	BTBD2 KLHL36 BTBD7	5.31e-03	61	108	3	PF07707
Pathway	WP_NEURAL_CREST_DIFFERENTIATION	SOX9 HDAC9 HDAC4 HOXB1 CTNNB1 HDAC1 HDAC2	1.72e-06	97	84	7	MM15926
Pathway	WP_NEURAL_CREST_DIFFERENTIATION	SOX9 HDAC9 HDAC4 HOXB1 CTNNB1 HDAC1 HDAC2	2.27e-06	101	84	7	M39448
Pathway	WP_RETT_SYNDROME	HIVEP2 GABBR2 CDKL5 SYNE2 HDAC1	9.33e-06	48	84	5	M39759
Pathway	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	HDAC9 HDAC4 HDAC1 HDAC2	2.15e-05	28	84	4	M6177
Pathway	BIOCARTA_RANBP2_PATHWAY	HDAC9 HDAC4 HDAC1	3.25e-05	11	84	3	M22027
Pathway	WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS	HDAC9 HDAC4 HDAC1 HDAC2	3.26e-05	31	84	4	M39714
Pathway	WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR	HDAC9 HDAC4 HDAC1 HDAC2	3.71e-05	32	84	4	M39521
Pathway	PID_HDAC_CLASSI_PATHWAY	HDAC9 HDAC4 MBD3 HDAC1 HDAC2	4.48e-05	66	84	5	M101
Pathway	REACTOME_SIGNALING_BY_NOTCH1	HDAC9 HDAC4 DTX1 HDAC1 HDAC2	7.77e-05	74	84	5	M616
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION	HLA-DOA HLA-DQA1 HLA-DQA2	8.82e-05	15	84	3	M47588
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES	HLA-DOA HLA-DQA1 HLA-DQA2	8.82e-05	15	84	3	M47604
Pathway	BIOCARTA_MTA3_PATHWAY	MBD3 CTSD HDAC1	1.56e-04	18	84	3	M225
Pathway	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	HDAC9 HDAC4 HDAC1 HDAC2	1.87e-04	48	84	4	M611
Pathway	WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS	NR4A1 HDAC1 HDAC2	2.16e-04	20	84	3	M48330
Pathway	WP_VEGFAVEGFR2_SIGNALING	HDAC9 P4HA2 HDAC4 RCN1 SRPK1 NR4A1 MMRN2 CTNNB1 CTNND1 HDAC1	2.35e-04	431	84	10	M39729
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	PRR5 LAMA2 LAMC1 PTPRU JUNB KIDINS220 CTNNB1 CTNND1 CTSD HDAC1 HDAC2	3.05e-04	532	84	11	M27870
Pathway	WP_HISTONE_MODIFICATIONS	HDAC1 HDAC2	3.47e-04	5	84	2	MM15874
Pathway	REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER	HDAC9 HDAC4 HDAC1 HDAC2	3.90e-04	58	84	4	M29616
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	P4HA2 LAMA2 LAMC1 ADAM8 ITGAX BMP1 LOXL1 CTSD	4.11e-04	300	84	8	M610
Pathway	REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS	HDAC9 HDAC4 PRR5 PSMB11 NR4A1 JUNB CTNNB1 GOLGA4 HDAC1 HDAC2	4.23e-04	464	84	10	M27547
Pathway	BIOCARTA_CARM_ER_PATHWAY	HDAC4 HDAC1 HDAC2	4.81e-04	26	84	3	M2499
Pathway	REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1	HDAC1 HDAC2	5.18e-04	6	84	2	M27072
Pathway	REACTOME_TCR_SIGNALING	HLA-DQA1 HLA-DQA2 PSMB11 MALT1 CD101	5.21e-04	111	84	5	MM14803
Pathway	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	HLA-DQA1 HLA-DQA2 CD101	5.38e-04	27	84	3	MM14809
Pathway	REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY	PRR5 CTNNB1 CTNND1	5.38e-04	27	84	3	M27422
Pathway	REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION	LAMA2 LAMC1 HDAC2	6.67e-04	29	84	3	M29808
Pathway	REACTOME_REGULATION_OF_CDH19_EXPRESSION_AND_FUNCTION	CTNNB1 CTNND1	7.23e-04	7	84	2	M48017
Pathway	REACTOME_CDH11_HOMOTYPIC_AND_HETEROTYPIC_INTERACTIONS	CTNNB1 CTNND1	7.23e-04	7	84	2	M48038
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION	HDAC1 HDAC2	7.23e-04	7	84	2	M47673
Pathway	KEGG_ASTHMA	HLA-DOA HLA-DQA1 HLA-DQA2	7.38e-04	30	84	3	M13950
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION	MBD3 HDAC1 HDAC2	7.38e-04	30	84	3	M27637
Pathway	REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY	PRR5 CTNNB1 CTNND1	7.38e-04	30	84	3	MM15170
Pathway	KEGG_VIRAL_MYOCARDITIS	HLA-DOA HLA-DQA1 HLA-DQA2 LAMA2	7.98e-04	70	84	4	M12294
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION	MBD3 HDAC1 HDAC2	8.13e-04	31	84	3	M48258
Pathway	REACTOME_TCR_SIGNALING	HLA-DQA1 HLA-DQA2 PSMB11 MALT1 CD101	8.61e-04	124	84	5	M15381
Pathway	WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS	P4HA2 BMP1 UGP2	8.94e-04	32	84	3	M48055
Pathway	REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX	SOX9 CTNNB1 HDAC1	8.94e-04	32	84	3	MM14975
Pathway	REACTOME_REGULATION_OF_CDH11_FUNCTION	CTNNB1 CTNND1	9.60e-04	8	84	2	MM17072
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION	CTNNB1 HDAC1	9.60e-04	8	84	2	MM17229
Pathway	REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS	CTNNB1 CTNND1	1.23e-03	9	84	2	M27781
Pathway	WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA	MBD3 HDAC1 HDAC2	1.37e-03	37	84	3	M39756
Pathway	KEGG_ALLOGRAFT_REJECTION	HLA-DOA HLA-DQA1 HLA-DQA2	1.37e-03	37	84	3	M18615
Pathway	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	HLA-DQA1 HLA-DQA2 CD101	1.60e-03	39	84	3	M16523
Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	HLA-DOA HLA-DQA1 HLA-DQA2	1.85e-03	41	84	3	M13519
Pathway	REACTOME_REGULATION_OF_CDH11_FUNCTION	CTNNB1 CTNND1	1.86e-03	11	84	2	M48015
Pathway	REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING	HDAC1 HDAC2	1.86e-03	11	84	2	M42523
Pathway	PID_RANBP2_PATHWAY	HDAC4 HDAC1	1.86e-03	11	84	2	M140
Pathway	PID_INTEGRIN4_PATHWAY	LAMA2 LAMC1	1.86e-03	11	84	2	M158
Pathway	KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION	HDAC1 HDAC2	1.86e-03	11	84	2	M47438
Pathway	KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS	NDST1 NDST2	1.86e-03	11	84	2	M47921
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	HLA-DOA HLA-DQA1 HLA-DQA2 KIR2DL4	1.87e-03	88	84	4	M16004
Pathway	REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX	SOX9 CTNNB1 HDAC1	1.98e-03	42	84	3	M27272
Pathway	KEGG_TYPE_I_DIABETES_MELLITUS	HLA-DOA HLA-DQA1 HLA-DQA2	2.12e-03	43	84	3	M12617
Pathway	REACTOME_REGULATION_OF_CDH11_EXPRESSION_AND_FUNCTION	CTNNB1 CTNND1	2.23e-03	12	84	2	MM17071
Pathway	REACTOME_DOWNSTREAM_TCR_SIGNALING	HLA-DQA1 HLA-DQA2 PSMB11 MALT1	2.29e-03	93	84	4	MM14806
Pathway	WP_NOTCH_SIGNALING_WP268	DTX1 HDAC1 HDAC2	2.42e-03	45	84	3	M39571
Pathway	WP_NOTCH_SIGNALING_PATHWAY	DTX1 HDAC1 HDAC2	2.58e-03	46	84	3	MM15971
Pathway	PID_PS1_PATHWAY	DTX1 CTNNB1 HDAC1	2.58e-03	46	84	3	M70
Pathway	KEGG_NOTCH_SIGNALING_PATHWAY	DTX1 HDAC1 HDAC2	2.74e-03	47	84	3	M7946
Pathway	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	MBD3 HDAC1 HDAC2	2.74e-03	47	84	3	M1095
Pubmed	Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor.	HDAC9 HDAC4 HDAC1 HDAC2	3.29e-09	7	110	4	11022042
Pubmed	Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.	HDAC9 HDAC4 HDAC1 HDAC2	6.57e-09	8	110	4	16288017
Pubmed	Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo.	HDAC9 HDAC4 HDAC1 HDAC2	1.18e-08	9	110	4	11466315
Pubmed	Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development.	HDAC9 HDAC4 HDAC1 HDAC2	1.18e-08	9	110	4	15367668
Pubmed	NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation.	HDAC4 CTNNB1 HDAC1 HDAC2	1.18e-08	9	110	4	19463978
Pubmed	Class II histone deacetylases: versatile regulators.	HDAC9 HDAC4 HDAC1 HDAC2	1.96e-08	10	110	4	12711221
Pubmed	Histone Deacetylase 1 Is Essential for Rod Photoreceptor Differentiation by Regulating Acetylation at Histone H3 Lysine 9 and Histone H4 Lysine 12 in the Mouse Retina.	HDAC9 HDAC4 HDAC1 HDAC2	1.96e-08	10	110	4	28028172
Pubmed	MAPT/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration.	HDAC9 HDAC4 HDAC1 HDAC2	3.07e-08	11	110	4	31223056
Pubmed	Sharp, an inducible cofactor that integrates nuclear receptor repression and activation.	SOX9 MBD3 HDAC1 HDAC2	3.07e-08	11	110	4	11331609
Pubmed	Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo.	HLA-DQA1 HLA-DQA2 ITGAX	3.08e-08	3	110	3	9053454
Pubmed	A novel role for methyl CpG-binding domain protein 3, a component of the histone deacetylase complex, in regulation of cell cycle progression and cell death.	MBD3 HDAC1 HDAC2	3.08e-08	3	110	3	19041848
Pubmed	HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1/HDAC2 to control H2BK120 acetylation and homology-directed repair.	HDAC4 HDAC1 HDAC2	3.08e-08	3	110	3	38874468
Pubmed	HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression.	HDAC9 HDAC4 HDAC1	3.08e-08	3	110	3	27333946
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	NDST1 RHBDD1 P4HA2 MAP1B RCN1 LAMC1 SLC39A10 PMEPA1 BMP1 PCYOX1L MAN1A2 LRP10 PRCP LOXL1 TMEM245 SEL1L3 CTNNB1 CTSD	4.26e-08	1201	110	18	35696571
Pubmed	Histone deacetylase expression patterns in developing murine optic nerve.	HDAC9 HDAC4 HDAC1 HDAC2	9.25e-08	14	110	4	25011550
Pubmed	Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin.	HDAC9 HDAC4 HDAC1 HDAC2	9.25e-08	14	110	4	15601857
Pubmed	Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis.	HDAC9 HDAC4 HDAC1 HDAC2	9.25e-08	14	110	4	15537544
Pubmed	Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9.	HDAC9 HDAC4 HDAC1 HDAC2	9.25e-08	14	110	4	21953612
Pubmed	HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination.	CTNNB1 HDAC1 HDAC2	1.23e-07	4	110	3	21423191
Pubmed	Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice.	HLA-DOA HLA-DQA1 HLA-DQA2	1.23e-07	4	110	3	11069069
Pubmed	Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.	HDAC4 HDAC1 HDAC2	1.23e-07	4	110	3	26502922
Pubmed	Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10.	HDAC9 HDAC4 HDAC1 HDAC2	1.67e-07	16	110	4	16873063
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	MAP1B NR4A1 JUNB KIDINS220 PAX8 ZFR CTNNB1 HDAC2	1.81e-07	191	110	8	20195357
Pubmed	HDAC family: What are the cancer relevant targets?	HDAC9 HDAC4 HDAC1 HDAC2	2.80e-07	18	110	4	18824292
Pubmed	Immediate effects of a single exercise bout on protein O-GlcNAcylation and chromatin regulation of cardiac hypertrophy.	HDAC4 HDAC1 HDAC2	3.06e-07	5	110	3	23624624
Pubmed	Autoacetylation regulates P/CAF nuclear localization.	HDAC4 HDAC1 HDAC2	3.06e-07	5	110	3	19015268
Pubmed	MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks.	MBD3 HDAC1 HDAC2	3.06e-07	5	110	3	18644863
Pubmed	The functional interactome landscape of the human histone deacetylase family.	HDAC9 HDAC4 RCN1 MBD3 SYNE2 SEC16A ZFR HDAC1 HDAC2	3.72e-07	289	110	9	23752268
Pubmed	Notch signaling augments the canonical Wnt pathway to specify the size of the otic placode.	SOX9 HOXB1 PAX8 CTNNB1	4.41e-07	20	110	4	18495817
Pubmed	A dynamic role for HDAC7 in MEF2-mediated muscle differentiation.	HDAC4 HDAC1 HDAC2	6.11e-07	6	110	3	11279209
Pubmed	MBD3 and HDAC1, two components of the NuRD complex, are localized at Aurora-A-positive centrosomes in M phase.	MBD3 HDAC1 HDAC2	6.11e-07	6	110	3	12354758
Pubmed	Two highly related p66 proteins comprise a new family of potent transcriptional repressors interacting with MBD2 and MBD3.	MBD3 HDAC1 HDAC2	6.11e-07	6	110	3	12183469
Pubmed	Expression and localization of components of the histone deacetylases multiprotein repressory complexes in the mouse preimplantation embryo.	MBD3 HDAC1 HDAC2	6.11e-07	6	110	3	14643676
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	SOX9 HDAC9 HDAC4 MBD3 TBR1 HDAC1 HDAC2	7.20e-07	157	110	7	30186101
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	SOX9 HDAC9 HIVEP2 TCF20 HDAC4 HNRNPUL1 SP8 HOXB1 JUNB PAX8 RBMX CTNNB1 HDAC1 HDAC2	7.42e-07	877	110	14	20211142
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	TCF20 MAP1B RCN1 LAMC1 HNRNPUL1 RCC2 HNRNPH2 PRPF4 RBMX SYNE2 SEC16A ZFR CTNNB1 CTNND1 HDAC2	8.48e-07	1024	110	15	24711643
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	TCF20 RBMXL1 HNRNPUL1 MBD3 JUNB RBMX MED13 HDAC1 HDAC2	8.92e-07	321	110	9	32098917
Pubmed	Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior.	HDAC4 CTNNB1 TBR1 HDAC1 HDAC2	9.70e-07	56	110	5	29184203
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	MAP1B MRPL13 SRPK1 HNRNPUL1 MBD3 RCC2 HNRNPH2 PRPF4 BTBD7 RBMX SEC16A ZFR CTNND1 TBR1 ELP4 HDAC1 HDAC2	1.02e-06	1335	110	17	29229926
Pubmed	HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF.	HDAC4 HDAC1 HDAC2	1.07e-06	7	110	3	15467736
Pubmed	The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase.	HDAC9 HDAC4 HDAC1	1.07e-06	7	110	3	12032081
Pubmed	Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR.	HDAC4 HDAC1 HDAC2	1.07e-06	7	110	3	11804585
Pubmed	CDK2AP1/DOC-1 is a bona fide subunit of the Mi-2/NuRD complex.	MBD3 HDAC1 HDAC2	1.07e-06	7	110	3	20523938
Pubmed	Altered antigen presentation in mice lacking H2-O.	HLA-DOA HLA-DQA1 HLA-DQA2	1.07e-06	7	110	3	9492004
Pubmed	Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase.	HDAC4 HDAC1 HDAC2	1.07e-06	7	110	3	19218564
Pubmed	TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.	HDAC4 CTNNB1 HDAC1	1.07e-06	7	110	3	16204248
Pubmed	Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.	RBMXL1 SRPK1 HNRNPUL1 HNRNPH2 RBMX ZFR	1.36e-06	109	110	6	29511296
Pubmed	Interactions of viral protein U (Vpu) with cellular factors.	HLA-DOA HLA-DQA1 HLA-DQA2 CTNNB1	1.57e-06	27	110	4	20012522
Pubmed	Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation.	HDAC9 HDAC4 HDAC1	1.70e-06	8	110	3	12242305
Pubmed	p21WAF1/CIP1 regulates the p300 sumoylation motif CRD1 through a C-terminal domain independently of cyclin/CDK binding.	HDAC4 HDAC1 HDAC2	1.70e-06	8	110	3	16082198
Pubmed	The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes.	MBD3 HDAC1 HDAC2	1.70e-06	8	110	3	11297506
Pubmed	MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.	MBD3 HDAC1 HDAC2	1.70e-06	8	110	3	12705869
Pubmed	Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.	MBD3 HDAC1 HDAC2	1.70e-06	8	110	3	10471500
Pubmed	Endosomal adaptor proteins APPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription.	CTNNB1 HDAC1 HDAC2	1.70e-06	8	110	3	19433865
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	LRFN1 TCF20 HDAC4 GABBR2 MBD3 ITIH4 SYNE2 SEC16A ELAVL3 ZFR CTNNB1 CTNND1 GOLGA4 HDAC2	2.22e-06	963	110	14	28671696
Pubmed	Functional dicer is necessary for appropriate specification of radial glia during early development of mouse telencephalon.	SOX9 ELAVL3 CTNNB1 TBR1	2.44e-06	30	110	4	21826226
Pubmed	The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment.	HDAC9 HDAC4 HDAC2	2.55e-06	9	110	3	16260608
Pubmed	Histone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2.	HDAC9 HDAC1 HDAC2	2.55e-06	9	110	3	26221039
Pubmed	The bZIP repressor proteins, c-Jun dimerization protein 2 and activating transcription factor 3, recruit multiple HDAC members to the ATF3 promoter.	HDAC4 HDAC1 HDAC2	2.55e-06	9	110	3	22989952
Pubmed	Identification and functional characterization of the p66/p68 components of the MeCP1 complex.	MBD3 HDAC1 HDAC2	2.55e-06	9	110	3	11756549
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	TCF20 JUNB SLC4A1AP SEC16A CTNNB1 CTNND1 CTSD ELP4 GOLGA4 HDAC2	2.70e-06	472	110	10	38943005
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	P4HA2 RCN1 SPART LAMC1 SRPK1 HNRNPUL1 MBD3 HNRNPH2 KIDINS220 PRCP RBMX SYNE2 ZFR CTNNB1 CTSD HDAC1	3.29e-06	1297	110	16	33545068
Pubmed	Increased interaction between DJ-1 and the Mi-2/ nucleosome remodelling and deacetylase complex during cellular stress.	MBD3 HDAC1 HDAC2	3.63e-06	10	110	3	20127688
Pubmed	Esco2 is a novel corepressor that associates with various chromatin modifying enzymes.	HDAC4 HDAC1 HDAC2	3.63e-06	10	110	3	18501190
Pubmed	Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression.	HDAC4 HDAC1 HDAC2	3.63e-06	10	110	3	15536134
Pubmed	Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation.	HDAC4 HDAC1 HDAC2	3.63e-06	10	110	3	15138260
Pubmed	Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes.	MBD3 HDAC1 HDAC2	3.63e-06	10	110	3	20388487
Pubmed	Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells.	HDAC4 HDAC1 HDAC2	3.63e-06	10	110	3	15619633
Pubmed	BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.	MBD3 HDAC1 HDAC2	3.63e-06	10	110	3	16091750
Pubmed	DNA Damage Regulates Translation through β-TRCP Targeting of CReP.	HIVEP2 ZNF395 CTNNB1 MED13	4.60e-06	35	110	4	26091241
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	LAMA2 LAMC1 ITIH4 LOXL1 MMRN2 CTSD	4.71e-06	135	110	6	28675934
Pubmed	MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.	MBD3 HDAC1 HDAC2	4.99e-06	11	110	3	15456747
Pubmed	DSCAM regulates delamination of neurons in the developing midbrain.	SOX9 ELAVL3 CTNNB1	4.99e-06	11	110	3	32917586
Pubmed	USP11 acts as a histone deubiquitinase functioning in chromatin reorganization during DNA repair.	MBD3 HDAC1 HDAC2	6.63e-06	12	110	3	31504778
Pubmed	HIV-1 Nef impairs MHC class II antigen presentation and surface expression.	HLA-DOA HLA-DQA1 HLA-DQA2	6.63e-06	12	110	3	11593029
Pubmed	Metastasis tumor antigen 2 (MTA2) is involved in proper imprinted expression of H19 and Peg3 during mouse preimplantation development.	MBD3 HDAC1 HDAC2	6.63e-06	12	110	3	20720167
Pubmed	Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.	MBD3 HDAC1 HDAC2	6.63e-06	12	110	3	21937684
Pubmed	Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.	HLA-DOA HLA-DQA1 HLA-DQA2	6.63e-06	12	110	3	12970439
Pubmed	Excess LINC complexes impair brain morphogenesis in a mouse model of recessive TOR1A disease.	SYNE2 CTNNB1 TBR1	6.63e-06	12	110	3	29868845
Pubmed	NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment.	MBD3 HDAC1 HDAC2	6.63e-06	12	110	3	22560079
Pubmed	CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.	P4HA2 MAP1B RCN1 LAMC1 RCC2 JUNB RBMX SEC16A CTSD	7.65e-06	418	110	9	35338135
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	HIVEP2 MAP1B MRPL13 ZNF395 HNRNPH2 ZFR CTNNB1	8.04e-06	226	110	7	25900982
Pubmed	The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2.	MBD3 HDAC1 HDAC2	8.60e-06	13	110	3	12124384
Pubmed	HDAC1 and HDAC2 orchestrate Wnt signaling to regulate neural progenitor transition during brain development.	SOX9 HDAC1 HDAC2	8.60e-06	13	110	3	39224519
Pubmed	LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.	MBD3 HDAC1 HDAC2	8.60e-06	13	110	3	19703393
Pubmed	Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).	MAP1B LAMA2 CTNND1	8.60e-06	13	110	3	16212419
Pubmed	HDAC1 and HDAC2 control the specification of neural crest cells into peripheral glia.	SOX9 HDAC1 HDAC2	8.60e-06	13	110	3	24760871
Pubmed	Fukutin-related protein alters the deposition of laminin in the eye and brain.	LAMA2 LAMC1 TBR1	8.60e-06	13	110	3	21900571
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	HIVEP2 MAP1B ZNF395 HNRNPUL1 RBMX ZFR CTNNB1	9.54e-06	232	110	7	25515538
Pubmed	Inhibition of β-catenin signaling by nongenomic action of orphan nuclear receptor Nur77.	NR4A1 CTNNB1	9.91e-06	2	110	2	21986938
Pubmed	A molecular basis for the Ia.2 and Ia.19 antigenic determinants.	HLA-DQA1 HLA-DQA2	9.91e-06	2	110	2	2581258
Pubmed	Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice.	HLA-DQA1 HLA-DQA2	9.91e-06	2	110	2	16322110
Pubmed	Clinicopathological significance of SOX9 and β-catenin expression in pre-neoadjuvant chemotherapy cases of osteosarcoma: molecular and immunohistochemical study.	SOX9 CTNNB1	9.91e-06	2	110	2	37013797
Pubmed	Sox9 is a β-catenin-regulated transcription factor that enhances the colony-forming activity of squamous cell carcinoma cells.	SOX9 CTNNB1	9.91e-06	2	110	2	27151141
Pubmed	Characterization of defective I-A surface expression in a mixed isotype expressing murine B cell lymphoma: continued expression of E alpha d A beta d despite competition from restored A alpha d A beta d pairs.	HLA-DQA1 HLA-DQA2	9.91e-06	2	110	2	1329933
Pubmed	Histone deacetylase HDA-1 modulates mitochondrial stress response and longevity.	HDAC1 HDAC2	9.91e-06	2	110	2	32934238
Pubmed	Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining.	HDAC1 HDAC2	9.91e-06	2	110	2	20802485
Pubmed	Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions.	HDAC1 HDAC2	9.91e-06	2	110	2	11919195
Pubmed	Genetic dissection of histone deacetylase requirement in tumor cells.	HDAC1 HDAC2	9.91e-06	2	110	2	19416910
Pubmed	HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells.	HDAC1 HDAC2	9.91e-06	2	110	2	31071955
Interaction	RAD18 interactions	RBMXL1 RCN1 SRPK1 HNRNPUL1 RCC2 JUNB SLC4A1AP PRPF4 KLHDC3 ZFR CTNNB1 CTNND1	6.87e-06	457	109	12	int:RAD18
Interaction	SMARCD2 interactions	SOX9 HDAC4 NR4A1 MBD3 PAX8 TBR1 HDAC1 HDAC2	6.90e-06	183	109	8	int:SMARCD2
Interaction	TRPS1 interactions	SOX9 MBD3 PAX8 SEC16A TBR1 HDAC1 HDAC2	1.27e-05	143	109	7	int:TRPS1
Interaction	COPS5 interactions	RCN1 SPART SRPK1 BTBD2 HNRNPUL1 FIGN RCC2 HNRNPH2 MALT1 MINDY3 PRPF4 KLHL36 KLHDC3 ZFR CTNNB1 ABTB2 PRLR HDAC1	2.45e-05	1102	109	18	int:COPS5
Interaction	MIDEAS interactions	SOX9 PAX8 SEC16A TBR1 HDAC1 HDAC2	2.67e-05	108	109	6	int:MIDEAS
Interaction	TBX3 interactions	HDAC4 RBMX CTNNB1 HDAC1 HDAC2	3.60e-05	69	109	5	int:TBX3
Interaction	FBXW11 interactions	HIVEP2 MAP1B RBMXL1 MRPL13 ZNF395 HNRNPUL1 HNRNPH2 RBMX ZFR CTNNB1 PRLR	5.14e-05	473	109	11	int:FBXW11
Interaction	MATR3 interactions	HDAC4 RBMXL1 RCN1 SRPK1 HNRNPUL1 HNRNPH2 AKTIP RBMX ZFR CTNNB1 CTNND1 HDAC1 HDAC2	5.35e-05	655	109	13	int:MATR3
Interaction	SMAD7 interactions	NR4A1 VNN1 CTNNB1 TBR1 HDAC1 HDAC2	6.63e-05	127	109	6	int:SMAD7
Interaction	SERPING1 interactions	RHBDD1 NR4A1 ITIH4 SEL1L3	7.74e-05	42	109	4	int:SERPING1
Interaction	JDP2 interactions	HDAC4 JUNB HDAC1 HDAC2	7.74e-05	42	109	4	int:JDP2
Interaction	IFRD1 interactions	HDAC4 CTNNB1 HDAC1 HDAC2	7.74e-05	42	109	4	int:IFRD1
Interaction	PPIA interactions	TCF20 MAP1B SRPK1 CDKL5 JUNB SLC4A1AP SEC16A CTNNB1 CTNND1 CTSD PRLR ELP4 GOLGA4 HDAC1 HDAC2	8.64e-05	888	109	15	int:PPIA
Interaction	ARID4B interactions	SOX9 HDAC4 SRPK1 MBD3 TBR1 HDAC1 HDAC2	1.05e-04	199	109	7	int:ARID4B
Interaction	TBL1X interactions	HDAC4 KLHDC3 CTNNB1 TBR1 HDAC1 HDAC2	1.05e-04	138	109	6	int:TBL1X
Interaction	HDAC7 interactions	LRFN1 HDAC4 UGP2 CTNNB1 HDAC1 HDAC2	1.18e-04	141	109	6	int:HDAC7
Interaction	TLE4 interactions	HNRNPUL1 PAX8 SYNE2 TBR1 HDAC1	1.43e-04	92	109	5	int:TLE4
Interaction	ZNF609 interactions	SOX9 PAX8 TBR1 ABTB2 HDAC1 HDAC2	1.43e-04	146	109	6	int:ZNF609
Interaction	TLE1 interactions	SOX9 HLA-DQA1 BTBD2 PAX8 CTNNB1 TBR1 HDAC1	1.60e-04	213	109	7	int:TLE1
Interaction	ZEB2 interactions	HDAC4 MBD3 PAX8 HDAC1 HDAC2	1.66e-04	95	109	5	int:ZEB2
Interaction	ZBTB7B interactions	TCF20 HDAC4 HNRNPUL1 MBD3 JUNB RBMX MED13 HDAC1 HDAC2	1.68e-04	366	109	9	int:ZBTB7B
Interaction	IKZF1 interactions	HDAC4 BTBD2 MBD3 KLHDC3 RBMX CTSD HDAC1 HDAC2	1.72e-04	288	109	8	int:IKZF1
Interaction	OTUB2 interactions	SPART NR4A1 PMEPA1 RCC2 CTNNB1	1.74e-04	96	109	5	int:OTUB2
Interaction	USP43 interactions	MBD3 CTNNB1 HDAC1 HDAC2	1.79e-04	52	109	4	int:USP43
Cytoband	6q23-q24	HIVEP2 VNN1	2.03e-04	9	110	2	6q23-q24
Cytoband	11p13	RCN1 ABTB2 ELP4	3.38e-04	56	110	3	11p13
Cytoband	Ensembl 112 genes in cytogenetic band chr11p13	RCN1 ABTB2 ELP4	5.25e-04	65	110	3	chr11p13
Cytoband	1p13	MAN1A2 CD101	7.56e-04	17	110	2	1p13
GeneFamily	PHD finger proteins\|NuRD complex	MBD3 HDAC1 HDAC2	1.59e-05	12	77	3	1305
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	HDAC1 HDAC2	1.07e-04	4	77	2	989
GeneFamily	Histone deacetylases, class IIA	HDAC9 HDAC4	1.07e-04	4	77	2	992
GeneFamily	Bone morphogenetic proteins\|Astacins	MEP1A BMP1	2.66e-04	6	77	2	894
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	HDAC1 HDAC2	6.32e-04	9	77	2	1306
GeneFamily	C1-set domain containing	HLA-DOA HLA-DQA1 HLA-DQA2	7.57e-04	42	77	3	591
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-DOA HLA-DQA1 HLA-DQA2	8.68e-04	44	77	3	588
GeneFamily	Laminin subunits	LAMA2 LAMC1	1.15e-03	12	77	2	626
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	HDAC1 HDAC2	1.15e-03	12	77	2	1243
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	BTBD2 KLHL36 BTBD7 ABTB2	2.57e-03	134	77	4	861
Coexpression	MARTINEZ_RB1_TARGETS_UP	SOX9 TCF20 MAP1B HLA-DQA1 HLA-DQA2 SRPK1 NR4A1 PMEPA1 RCC2 BMP1 JUNB MAN1A2 ZFR GOLGA4	2.48e-06	741	109	14	MM1037
Coexpression	WANG_LMO4_TARGETS_UP	RBMXL1 BTBD2 HNRNPUL1 FIGN MINDY3 TLK1 MAN1A2 RIN2 CTNNB1 ABTB2	3.52e-06	371	109	10	M4735
Coexpression	MARTINEZ_RB1_TARGETS_UP	SOX9 TCF20 MAP1B HLA-DQA1 SRPK1 NR4A1 PMEPA1 RCC2 BMP1 JUNB MAN1A2 ZFR GOLGA4	6.00e-06	690	109	13	M12224
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	EPOR HIVEP2 PRR5 SLC39A10 GABBR2 PMEPA1 CDKL5 JUNB UGP2 PCDH1 GOLGA4	8.39e-06	504	109	11	M2157
Coexpression	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	EPOR ADAM8 JUNB LRP10 UGP2 CTSD	9.22e-06	116	109	6	M2222
Coexpression	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP	ZNF703 MRPL13 HNRNPH2 JUNB AKTIP ZFR HDAC2	2.09e-05	200	109	7	M9640
Coexpression	TABULA_MURIS_SENIS_LIVER_MYELOID_LEUKOCYTE_AGEING	HLA-DQA1 HLA-DQA2 NR4A1 JUNB	4.04e-05	46	109	4	MM3755
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	ZNF703 NDST1 LAMC1 HNRNPUL1 PTPRU AKIP1 PMEPA1 MALT1 JUNB BTBD7 RIN2 SYNE2 PCDH1	4.88e-05	843	109	13	M2356
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SOX9 HIVEP2 HDAC4 MAP1B SPART LAMC1 MALT1 TLK1 KIDINS220 RIN2 SYNE2 MED13 GOLGA4	5.71e-05	856	109	13	M4500
Coexpression	NABA_ECM_REGULATORS	P4HA2 ADAM8 ITIH4 MEP1A BMP1 LOXL1 CTSD	6.33e-05	238	109	7	M3468
Coexpression	NABA_ECM_REGULATORS	P4HA2 ADAM8 ITIH4 MEP1A BMP1 LOXL1 CTSD	7.02e-05	242	109	7	MM17062
Coexpression	HALLMARK_TGF_BETA_SIGNALING	PMEPA1 JUNB CTNNB1 HDAC1	7.62e-05	54	109	4	M5896
Coexpression	LEIN_CHOROID_PLEXUS_MARKERS	LRP10 SYNE2 CFAP44 PRLR TMPRSS11A	7.87e-05	105	109	5	M1719
Coexpression	GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN	NDST1 HLA-DQA1 ADAM8 ITGAX SEL1L3 CTSD	9.32e-05	175	109	6	M5660
Coexpression	LEIN_CHOROID_PLEXUS_MARKERS	LRP10 SYNE2 CFAP44 PRLR TMPRSS11A	9.40e-05	109	109	5	MM1214
Coexpression	BERNARD_PPAPDC1B_TARGETS_DN	ZNF703 HDAC4 SEL1L3 PRLR	1.08e-04	59	109	4	M8123
Coexpression	ERBB2_UP.V1_UP	SOX9 P4HA2 PTPRU GABBR2 LOXL1 PCDH1	1.46e-04	190	109	6	M2636
Coexpression	MARTINEZ_TP53_TARGETS_UP	MAP1B HLA-DQA1 HLA-DQA2 NDST2 LAMA2 SRPK1 NR4A1 PMEPA1 BMP1 MAN1A2 ZFR	1.52e-04	694	109	11	MM1039
Coexpression	GSE20727_CTRL_VS_H2O2_TREATED_DC_DN	HDAC9 NR4A1 ZC3H6 JUNB PCYOX1L KLHL36	1.73e-04	196	109	6	M9243
Coexpression	GSE3982_MAST_CELL_VS_NEUTROPHIL_DN	HDAC9 HNRNPH2 JUNB PRCP SYNE2 KIR2DL4	1.78e-04	197	109	6	M5433
Coexpression	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN	HDAC4 MAP1B RCN1 PMEPA1 KLHDC3 HRH3	1.88e-04	199	109	6	M5070
Coexpression	GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP	HDAC4 RCN1 RCC2 TMEM245 TMPRSS11A HDAC2	1.88e-04	199	109	6	M4341
Coexpression	GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN	P4HA2 DTX1 ITIH4 BMP1 ADPRM SAMD10	1.93e-04	200	109	6	M8220
Coexpression	GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN	HDAC9 HIVEP2 HLA-DOA ADAM8 ITGAX PRCP	1.93e-04	200	109	6	M4968
Coexpression	GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP	ZNF703 RHBDD1 NDST2 SRPK1 NR4A1 RBMX	1.93e-04	200	109	6	M3663
Coexpression	GSE22886_NAIVE_CD8_TCELL_VS_DC_UP	HIVEP2 PRR5 HNRNPUL1 AKTIP ADPRM SYNE2	1.93e-04	200	109	6	M4490
Coexpression	ACEVEDO_LIVER_CANCER_UP	P4HA2 MRPL13 SRPK1 ADPRM KIDINS220 LRP10 SLC4A1AP TMEM245 RBMX RIN2 ZFR GOLGA4 HDAC2	2.02e-04	972	109	13	M15709
Coexpression	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	GABBR2 CDKL5 MALT1 AKTIP LOXL1 TMEM245 RIN2 CTNNB1 CTNND1	2.15e-04	491	109	9	M13661
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000	SOX9 NDST1 DTX1 PRR5 LAMA2 ZNF395 BMP1 TLK1 VNN1 LOXL1 SYNE2 SEL1L3 ZFR CTNNB1 CTNND1 PRLR	3.38e-06	819	107	16	gudmap_developingGonad_P2_testes_1000
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1	HDAC9 HLA-DOA HLA-DQA1 DTX1 NR4A1 ADAM8 ITGAX MALT1 RIN2 CD101	2.36e-05	382	107	10	GSM538248_500
ToppCell	mild_COVID-19-cDC\|World / disease group, cell group and cell class (v2)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ITGAX RCC2 PRCP CTNND1	1.56e-09	197	110	9	63e7b040c64f1e28b8db79980c7b580caa7d1b95
ToppCell	COVID-19-COVID-19_Mild-Myeloid-cDC\|COVID-19_Mild / Disease, condition lineage and cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ADAM8 ITGAX RCC2 PRCP	1.78e-09	200	110	9	b8f52e65813d331c49cdd5f354fdfec6fc8c339e
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 ITGAX RCC2 PRCP CD101 CTNND1	5.57e-09	157	110	8	e9d0300361b06aec3c216f8af15f09e14b12a4da
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 ITGAX RCC2 PRCP CD101 CTNND1	5.85e-09	158	110	8	e9657d8960d499832f9f9b45b5a6f4388551b7e1
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 NR4A1 ADAM8 ITGAX RCC2 PRCP	2.68e-08	192	110	8	dfb9101622f7d2f2c392e850cff07becfc8c655e
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 NR4A1 ADAM8 ITGAX RCC2 PRCP	2.68e-08	192	110	8	d39133cf1a20af6f2970188630fc3b27a4cfc9c5
ToppCell	COVID-19_Severe-cDC\|COVID-19_Severe / disease group, cell group and cell class	HDAC9 HLA-DOA HLA-DQA1 NR4A1 ADAM8 ITGAX RCC2 PRCP	3.03e-08	195	110	8	6419090b19de7b5d5140eaecf231860273da2c0d
ToppCell	COVID-19_Moderate-cDC\|World / disease group, cell group and cell class	HDAC9 HLA-DOA HLA-DQA1 NR4A1 ADAM8 ITGAX RCC2 PRCP	3.15e-08	196	110	8	92a236adf386f05d020b1954bbdc5bd32346cbf0
ToppCell	Healthy/Control-cDC\|World / Disease group and Cell class	HDAC9 HLA-DOA HLA-DQA1 NR4A1 ITGAX RCC2 PRCP CTNND1	3.28e-08	197	110	8	4497d4073f4d3e74de907325fba9eb4af5766bf4
ToppCell	mild_COVID-19-cDC\|mild_COVID-19 / disease group, cell group and cell class (v2)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 RCC2 PRCP CTNND1	3.28e-08	197	110	8	44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6
ToppCell	Healthy-cDC\|Healthy / disease group, cell group and cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ADAM8 ITGAX RCC2 PRCP	3.41e-08	198	110	8	4cf874333b9fd6cd22ee647cd12c032fc6d05740
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	RHBDD1 P4HA2 HDAC4 HLA-DQA2 MALT1 RIN2 CD101	2.51e-07	173	110	7	b9dee61973559e8c2fef3f2dafd43475b386befb
ToppCell	mild_COVID-19_(asymptomatic)-cDC\|World / disease group, cell group and cell class (v2)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 RCC2 MALT1 CTNND1	3.28e-07	180	110	7	68d1c867734fb2977b01ac686b20bf602f9a6b72
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ITGAX RCC2 PRCP	4.56e-07	189	110	7	c81b38cda4525254fe4fa137a4c9bc9abe0363bb
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ITGAX RCC2 PRCP	4.56e-07	189	110	7	807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	MAP1B RCN1 LAMA2 LAMC1 BMP1 HOXB1 LOXL1	4.90e-07	191	110	7	9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279
ToppCell	(3)_MNP-(3)_DC_2\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ADAM8 JUNB	4.90e-07	191	110	7	3ff163484af8c12ef4eef87246cf044257fd2547
ToppCell	droplet-Fat-Scat-18m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P4HA2 RCN1 LAMA2 LAMC1 BMP1 SRPX2 LOXL1	5.25e-07	193	110	7	316ebdf15f75d88c348f909b643fcd315364ca84
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 PRCP CTNND1	5.25e-07	193	110	7	6b3a2a32ec6dc96230cee4bbf03932f8a81e6683
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 PRCP CTNND1	5.25e-07	193	110	7	b18c61e360f5f094f260007a56b189e2a48369e4
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX9 LAMA2 LAMC1 PMEPA1 SRPX2 LOXL1 UGP2	5.25e-07	193	110	7	24ce1f37cca655415410d2403a52d1ebb3332280
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P4HA2 LAMA2 LAMC1 BMP1 SRPX2 LOXL1 UGP2	5.25e-07	193	110	7	160691b671710be10220803d788c2c961c236af1
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	5.44e-07	194	110	7	b16ed97eb6b7b7a220e943474c0d85c141b6e3a5
ToppCell	facs-SCAT-Fat-3m-Mesenchymal\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P4HA2 RCN1 LAMA2 LAMC1 BMP1 SRPX2 LOXL1	5.44e-07	194	110	7	14b614f039bc866a1348a2728a68b7d254c7748c
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	5.44e-07	194	110	7	2210f0755882d8f04edb4c109fb17c3f9149f6f7
ToppCell	facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P4HA2 RCN1 LAMA2 LAMC1 BMP1 SRPX2 LOXL1	5.44e-07	194	110	7	68c7bfead1158641928cc276f599b4a79e06c73c
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX9 LAMA2 LAMC1 PMEPA1 SRPX2 LOXL1 UGP2	5.44e-07	194	110	7	2d0cff9dc538a14518741e2a96d9d78442c81a72
ToppCell	Control-Myeloid-Migratory_DC\|Control / Condition, Lineage and Cell class	HIVEP2 AOC1 HLA-DQA1 HLA-DQA2 NR4A1 ADAM8 MALT1	5.44e-07	194	110	7	374076e60dcee83eb1814aa6b55b77668909f40b
ToppCell	facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P4HA2 RCN1 LAMA2 LAMC1 BMP1 SRPX2 LOXL1	5.44e-07	194	110	7	f6aeae6a1e4017e341323fd4784c9e3bae00552b
ToppCell	Control-cDC-\|Control / Disease condition and Cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ADAM8 RCC2 PRCP	5.63e-07	195	110	7	a2b4d9473eff73f088b247ce43e66f013622471e
ToppCell	(010)_cDC\|World / immune cells in Peripheral Blood (logTPM normalization)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	5.63e-07	195	110	7	4aabb3f5ce70100e4d98d7fa9f8d12e84fb9fe3d
ToppCell	Control-cDC\|Control / Disease condition and Cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ADAM8 RCC2 PRCP	5.63e-07	195	110	7	b96acdd22dd3885af69328f170ea871a0d570034
ToppCell	PBMC-Control-Myeloid-cDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	5.83e-07	196	110	7	e1f763fa9c11bf5f4d80e79f70f9485724ac23fe
ToppCell	Control-Myeloid-cDC\|Control / Disease group, lineage and cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	5.83e-07	196	110	7	85d92bc226cc28384c30991cc4ebb02ec2e3ec99
ToppCell	COVID-mDC2\|COVID / Condition, Cell_class and T cell subcluster	HDAC9 HLA-DOA HLA-DQA1 ITGAX RCC2 PRCP CTNND1	5.83e-07	196	110	7	bb13926bb664be917017edb0ce7f184abe31744b
ToppCell	PBMC-Control-Myeloid-cDC-cDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	5.83e-07	196	110	7	553c22c7d48f3b4f6f2b2f10d6e668c5ebb09e8c
ToppCell	facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX9 RCN1 LAMA2 LAMC1 PMEPA1 LOXL1 UGP2	5.83e-07	196	110	7	ad1838dabd043cb140260843e3527d8c7d58850e
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	5.83e-07	196	110	7	0bac14c018487ca67e7f9255b5f186e7ae665774
ToppCell	COVID-mDC2-\|COVID / Condition, Cell_class and T cell subcluster	HDAC9 HLA-DOA HLA-DQA1 ITGAX RCC2 PRCP CTNND1	5.83e-07	196	110	7	6d02a4c5c19be7e036150cf945585cf5a773bc87
ToppCell	PBMC-Control-Myeloid-cDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	5.83e-07	196	110	7	d376168e15ec1cf618723259966c76be3698b9b0
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	5.83e-07	196	110	7	33345338c825484960daa1ed82a19df38ccfc5c0
ToppCell	Control-Myeloid-DC2\|Control / Condition, Lineage and Cell class	HDAC9 HLA-DQA1 HLA-DQA2 NR4A1 ADAM8 MALT1 PRCP	5.83e-07	196	110	7	0ccc26c2811e4c8631e0abd8555b167ac1e7a982
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	ADAM8 ITGAX CATSPER1 SYNE2 KIR2DL4 CTSD PCDH1	5.83e-07	196	110	7	f7e5a7fad4547e8ab9ab8b140239281832fb4260
ToppCell	PBMC-Control-Myeloid-cDC-cDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	5.83e-07	196	110	7	4a9095ba3f6709f88f32bf09184553f4bd211f43
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	HLA-DOA HLA-DQA1 ITGAX SAMD10 PRCP SEL1L3 CTNND1	5.83e-07	196	110	7	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX9 RCN1 LAMA2 LAMC1 PMEPA1 LOXL1 UGP2	5.83e-07	196	110	7	cbc15c0769016fe9972445169029bd8d14a7e6ef
ToppCell	PBMC-Mild-Myeloid-cDC-cDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ITGAX PRCP	6.03e-07	197	110	7	9162ede5572326c00ede0769fe7f4e0dd14d2340
ToppCell	PBMC-Mild-Myeloid-cDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ITGAX PRCP	6.03e-07	197	110	7	021c9c48375259b808e1f36a029c4fe6971c00eb
ToppCell	PBMC-Mild-Myeloid-cDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ITGAX PRCP	6.03e-07	197	110	7	18df0e447bcea2a405a357563f87bacc57466227
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-tip_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MAP1B LAMC1 HSPA12B PRCP MMRN2 CTNND1 PCDH1	6.03e-07	197	110	7	b212ff28ca2d1fea4140f186ab90941bdca21249
ToppCell	PBMC-Mild-Myeloid-cDC-cDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ITGAX PRCP	6.03e-07	197	110	7	0460b6907743a354792b5bc40bff01aac7c41684
ToppCell	COVID-19_Mild-Myeloid-cDC\|COVID-19_Mild / Disease group, lineage and cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ITGAX PRCP	6.03e-07	197	110	7	2901904b8a791fac2668fd737eff7e7144378db4
ToppCell	VE-mDC2-\|VE / Condition, Cell_class and T cell subcluster	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX PRCP CTNND1	6.03e-07	197	110	7	6629588819ec31a7e4f33b94b8c035145a5f6c17
ToppCell	Control-Myeloid-DC2\|Myeloid / Condition, Lineage and Cell class	HDAC9 HLA-DQA1 HLA-DQA2 NR4A1 ADAM8 MALT1 PRCP	6.03e-07	197	110	7	e0ee15188ff0d9df3c3b5ea523553ce18d223c33
ToppCell	Healthy/Control-cDC\|Healthy/Control / Disease group and Cell class	HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 ITGAX RCC2 PRCP	6.03e-07	197	110	7	926423aae9fcf654f84b0f7621103a6a22d3aced
ToppCell	Healthy_donor-cDC\|World / disease group, cell group and cell class (v2)	HLA-DOA HLA-DQA1 NR4A1 ITGAX RCC2 PRCP CTNND1	6.03e-07	197	110	7	a545fe3a80cd721bf01115bbb645753840ec9f40
ToppCell	VE-mDC2\|VE / Condition, Cell_class and T cell subcluster	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX PRCP CTNND1	6.03e-07	197	110	7	e3172102ad17c92c3038cad37bf933eb04351048
ToppCell	Healthy-cDC\|World / disease group, cell group and cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	6.24e-07	198	110	7	8976f8d26cb7ff79f74def138c4bbbb0bc2eaf00
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	P4HA2 LAMA2 LAMC1 PMEPA1 BMP1 SRPX2 LOXL1	6.24e-07	198	110	7	8b9e8eaeffda40912a0163fdf39b93bc5e64751c
ToppCell	COVID-19_Severe-cDC\|World / disease group, cell group and cell class	HDAC9 HLA-DOA HLA-DQA1 NR4A1 ITGAX RCC2 PRCP	6.24e-07	198	110	7	c452334249f047265ae89dcabe7de446d968cae6
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HDAC9 AOC1 HLA-DOA HLA-DQA1 HLA-DQA2 ADAM8 MALT1	6.45e-07	199	110	7	946d904a880c0e211861fcec7e120853ffade282
ToppCell	BAL-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	HLA-DOA HLA-DQA1 HLA-DQA2 SLC39A10 JUNB PRCP CTNND1	6.45e-07	199	110	7	da180aaa53f995183522da0f2321bf0c0c8ee6ec
ToppCell	Int-URO-Myeloid-cDC2\|Int-URO / Disease, Lineage and Cell Type	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 MRPL13 PRCP HDAC2	6.45e-07	199	110	7	7bbeda66f522b803f85be65d1a81555e12585efc
ToppCell	mild-cDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	6.67e-07	200	110	7	86f585bf9066b179bbcbc703bf43f15da4a07284
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	P4HA2 MAP1B RCN1 LAMA2 SRPX2 CPT1C LOXL1	6.67e-07	200	110	7	7642a14855589b0b3f68dbdc9e4d3fc7291854f7
ToppCell	Control-Control-Myeloid-cDC\|Control / Disease, condition lineage and cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	6.67e-07	200	110	7	1375d199320feb85ba06e74b10df6521e790addf
ToppCell	COVID-19-COVID-19_Severe-Myeloid-cDC\|COVID-19_Severe / Disease, condition lineage and cell class	HDAC9 HLA-DOA HLA-DQA1 NR4A1 ADAM8 ITGAX PRCP	6.67e-07	200	110	7	e7b808d8ed65343a4345fafb03015fe4f7ce302f
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	P4HA2 MAP1B LAMA2 PMEPA1 BMP1 SRPX2 LOXL1	6.67e-07	200	110	7	082e718c1da3f4fdd33a001d15ad3ddb2be985c7
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	P4HA2 MAP1B RCN1 LAMA2 SRPX2 CPT1C LOXL1	6.67e-07	200	110	7	444c72334df421375ae6fc69b0adfd4950d49a43
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	P4HA2 MAP1B RCN1 LAMA2 SRPX2 CPT1C LOXL1	6.67e-07	200	110	7	5826c17da67bdaba3a828792279004218d8260c8
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	P4HA2 MAP1B LAMA2 PMEPA1 BMP1 SRPX2 LOXL1	6.67e-07	200	110	7	731e55070a7ff315091855bd88cda30e5a7e1a98
ToppCell	control-cDC\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	6.67e-07	200	110	7	4a6d17a4225be38537d3dd8a39512051f597f4e0
ToppCell	Sepsis-Int-URO-Myeloid-cDC2\|Int-URO / Disease, condition lineage and cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 MRPL13 PRCP HDAC2	6.67e-07	200	110	7	dd8ac355b3b0394fda005789f9f2ff6560a02dac
ToppCell	mild-cDC\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX RCC2 PRCP	6.67e-07	200	110	7	d6409ee5b9067be3dd2f852825e09151b5b22d7c
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX PRCP	2.42e-06	155	110	6	ab539c04f10276ae919d82b1c75f99a84eb695bf
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX PRCP	2.42e-06	155	110	6	9a27558c457f05808af07190b7a5006b047f1d58
ToppCell	CD8+_Memory_T_cell-RSV-6\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	P4HA2 HIVEP2 TCF20 ZNF395 HNRNPH2 PAX8	2.70e-06	158	110	6	5ae737757a49fc96bde1e57e02066f9f65654ea1
ToppCell	ICU-NoSEP-Myeloid-cDC2\|ICU-NoSEP / Disease, Lineage and Cell Type	HDAC9 TMC7 HLA-DOA HLA-DQA1 HLA-DQA2 PRCP	3.72e-06	167	110	6	5b7b731944d888591279ef6167b3ae8cab3f6886
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 HLA-DQA2 DTX1 ZNF395 PMEPA1 SEL1L3	4.26e-06	171	110	6	b6ee3a6bc436df5e9129b8e0bed9fa3078a4ff23
ToppCell	facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HLA-DOA HLA-DQA1 ADAM8 ITGAX MALT1 PRCP	4.41e-06	172	110	6	eaba10a4d4eaab42ad2e2da65ebb20b50edaf815
ToppCell	Influenza_Severe-B_intermediate\|Influenza_Severe / Disease group and Cell class	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 PMEPA1 SEL1L3	4.71e-06	174	110	6	4276bdaac53aebd3084323a90ecde572d3177446
ToppCell	Dendritic_Cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	HDAC9 AOC1 HLA-DOA HLA-DQA1 HLA-DQA2 ADAM8	5.20e-06	177	110	6	d2cd081bdda0eba9f6f6473c4d3939e4bee3440e
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 SLC39A10 CTNND1	6.49e-06	184	110	6	1c56378b3888c46258d446b47de4d6282fe74b0d
ToppCell	lymphoid-NK_cell-TNFRSF18+IL7R-_NK_cell\|lymphoid / Lineage, cell class and subclass	ADAM8 ITGAX CATSPER1 MMRN2 KIR2DL4 CTSD	6.49e-06	184	110	6	62a3918705a3fcf3ef25c9ceb80f575a2e56ef76
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 SLC39A10 CTNND1	6.49e-06	184	110	6	a45980306c4e697a2703bed72a7b48fb23d942f4
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SOX9 MAP1B LAMA2 LAMC1 SRPX2 LOXL1	6.70e-06	185	110	6	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	CF-Myeloid-cDC\|CF / Disease state, Lineage and Cell class	HLA-DOA HLA-DQA1 HLA-DQA2 RCC2 MALT1 SEL1L3	6.70e-06	185	110	6	7f3d118845ff9f5f525796b0bbc6532a8ee323ab
ToppCell	COVID_vent-Myeloid-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX PRCP	6.90e-06	186	110	6	63a5cdd3f60681762a218be32db84be8f29b88fd
ToppCell	COVID_vent-Myeloid-Dendritic-cDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 ITGAX PRCP	6.90e-06	186	110	6	39457a7b43537f2c3e221f9375c95d4515424d7d
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 SEL1L3	6.90e-06	186	110	6	d7d884ff4184636081c350d29f797bd923c6a3b4
ToppCell	severe_influenza-B_intermediate\|severe_influenza / disease group, cell group and cell class (v2)	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 PMEPA1 SEL1L3	7.12e-06	187	110	6	d6db8595aa72fdabc4a056ba6ce09876868a66d5
ToppCell	(1)_B_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	HLA-DOA HLA-DQA1 HLA-DQA2 LAMC1 PMEPA1 SEL1L3	7.34e-06	188	110	6	642a334f2d5b6dc9df4a9fa0558833bd37bd3c58
ToppCell	(10)_B_cell\|World / immune cells in Peripheral Blood (logTPM normalization)	HLA-DOA HLA-DQA1 HLA-DQA2 LAMC1 PMEPA1 SEL1L3	7.34e-06	188	110	6	fa1346902021c3a6557555ada0fd37b29cf9d5ec
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 LAMC1 PMEPA1 BMP1 LOXL1 UGP2	7.34e-06	188	110	6	7191087d8754f5e8700e3d744cd920ee26db1e57
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_activate-7\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 HLA-DOA HLA-DQA1 HLA-DQA2 NR4A1 PMEPA1	7.57e-06	189	110	6	ef33cc03728a78423ee92d2ef1ffed4918d4221f
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 LAMC1 PMEPA1 BMP1 LOXL1 UGP2	7.57e-06	189	110	6	0a8b827bba1efd885ad6c06929251c741dc3a541
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	NR4A1 TMEM245 SYNE2 ABTB2 PRLR GOLGA4	7.57e-06	189	110	6	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQA1 HLA-DQA2 DTX1 LAMC1 PMEPA1 SEL1L3	7.80e-06	190	110	6	112706d64ee73b55dcf76f33ca064ab1fc6ce87f
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells\|bone_marrow / Manually curated celltypes from each tissue	HLA-DOA HLA-DQA1 HLA-DQA2 DTX1 PMEPA1 SEL1L3	7.80e-06	190	110	6	3d45d5011305f13634013d9eeb98f235517dd54e
ToppCell	(2)_Dendritic_Cells\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	HLA-DOA HLA-DQA1 HLA-DQA2 ADAM8 ITGAX RIN2	7.80e-06	190	110	6	5163a5be95fb6c2609bfa3d69166af172f74e724
Drug	Rodeo	HDAC9 HDAC4 KLHDC3 HDAC1 HDAC2	1.36e-08	17	109	5	CID000038078
Drug	AC1NV99J	HDAC9 HDAC4 HDAC1 HDAC2	8.65e-07	16	109	4	CID005474719
Drug	AC1L1EXH	HDAC9 HDAC4 HDAC1 HDAC2	1.44e-06	18	109	4	CID000002992
Drug	NSC3852	HDAC9 HDAC4 HDAC1 HDAC2	2.27e-06	20	109	4	CID000019103
Drug	BT-B	HDAC9 HDAC4 MAP1B BTBD2 BTBD7 CTNNB1 CTNND1 HDAC1 HDAC2	2.61e-06	243	109	9	CID000081462
Drug	Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SOX9 EPOR NR4A1 BMP1 JUNB RIN2 MMRN2 PCDH1	4.22e-06	193	109	8	3446_UP
Drug	AC1L1EA5	HDAC9 HDAC4 HDAC1 HDAC2	4.91e-06	24	109	4	CID000002706
Drug	Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SOX9 EPOR HIVEP2 GABBR2 JUNB BTBD7 RIN2 ELAVL3	4.91e-06	197	109	8	3467_UP
Drug	CI-994	HDAC9 HDAC1 HDAC2	1.25e-05	10	109	3	CID000002746
Drug	diisopropylacetic acid	HDAC9 CTNNB1	2.27e-05	2	109	2	CID000096832
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	HDAC9 NDST1 HIVEP2 TLK1 MLH3 ADPRM RIN2	2.42e-05	178	109	7	5086_DN
Drug	cerium dimer	MEP1A HOXB1 TMEM245 CTSD	2.91e-05	37	109	4	CID000139339
Drug	Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A	SOX9 EPOR NDST2 GABBR2 TLK1 MLH3 CTNNB1	4.19e-05	194	109	7	3861_DN
Drug	Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	SOX9 EPOR NDST2 BMP1 MALT1 PAX8 ELAVL3	4.19e-05	194	109	7	6779_DN
Drug	(R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A	EPOR SPART PTPRU GABBR2 ADPRM KLHL36 BTBD7	4.19e-05	194	109	7	6794_DN
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A	NDST1 HIVEP2 PRR5 NR4A1 GABBR2 BMP1 VNN1	4.33e-05	195	109	7	5990_UP
Drug	Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A	HIVEP2 HNRNPUL1 NR4A1 MINDY3 MLH3 KIDINS220 SEL1L3	4.33e-05	195	109	7	1886_DN
Drug	Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A	EPOR MAP1B BMP1 JUNB ADPRM PCDH1 PRLR	4.47e-05	196	109	7	3420_UP
Drug	5162773; Down 200; 7uM; MCF7; HT_HG-U133A_EA	EPOR NDST2 BTBD2 MBD3 BMP1 MINDY3 BTBD7	4.47e-05	196	109	7	892_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A	EPOR SPART PTPRU GABBR2 BMP1 KIDINS220 BTBD7	4.47e-05	196	109	7	2219_DN
Drug	Clorgyline hydrochloride [17780-75-5]; Up 200; 13uM; HL60; HG-U133A	NDST1 NDST2 MINDY3 MLH3 ADPRM CD101 SEL1L3	4.47e-05	196	109	7	1604_UP
Drug	Salbutamol [18559-94-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A	AOC1 SPART NR4A1 GABBR2 ITGAX PAX8 ELAVL3	4.47e-05	196	109	7	2306_UP
Drug	Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A	NDST1 HIVEP2 GABBR2 TLK1 MLH3 BTBD7 PCDH1	4.62e-05	197	109	7	3798_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	EPOR MAP1B MBD3 BMP1 KIDINS220 KLHL36 BTBD7	4.62e-05	197	109	7	7440_DN
Drug	Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	NDST1 GABBR2 BMP1 ADPRM KIDINS220 KLHL36 PRLR	4.62e-05	197	109	7	5317_UP
Drug	Altretamine [654-05-6]; Up 200; 19uM; HL60; HT_HG-U133A	GABBR2 MLH3 KIDINS220 RIN2 CTNND1 ABTB2 HRH3	4.62e-05	197	109	7	3090_UP
Drug	Biotin [58-85-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A	EPOR NDST1 TMC7 NDST2 MBD3 BMP1 RIN2	4.77e-05	198	109	7	3289_DN
Drug	Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A	SOX9 EPOR NDST1 BTBD2 ADAM8 BTBD7 RIN2	4.92e-05	199	109	7	3444_UP
Drug	novobiocin sodium, USP; Up 200; 100uM; ssMCF7; HG-U133A	EPOR SPART NR4A1 MBD3 HOXB1 MINDY3 PAX8	4.92e-05	199	109	7	499_UP
Drug	Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A	MAP1B SPART PTPRU MBD3 MINDY3 ABTB2 PRLR	4.92e-05	199	109	7	2756_DN
Drug	monomethyl phthalate	TCF20 HDAC4 HLA-DQA2 DTX1 RCN1 PMEPA1 BMP1 TLK1 MAN1A2 CTNNB1 CTNND1 TBR1 CTSD HRH3 HDAC1	5.12e-05	957	109	15	ctd:C517284
Disease	autism spectrum disorder (implicated_via_orthology)	NDST1 TCF20 NDST2 LAMC1 CTNNB1 CTNND1 TBR1	1.25e-06	152	105	7	DOID:0060041 (implicated_via_orthology)
Disease	coronary artery disease	HDAC9 P4HA2 HIVEP2 MAP1B HLA-DQA1 LAMC1 HNRNPUL1 PTPRU FIGN PMEPA1 ITIH4 BMP1 SP8 LOXL1 RBMX	2.15e-05	1194	105	15	EFO_0001645
Disease	skin aging measurement	P4HA2 HDAC4 KIDINS220 LOXL1 SYNE2 PRLR	4.77e-05	181	105	6	EFO_0008006
Disease	chronic hepatitis B virus infection	HLA-DOA HLA-DQA1 HLA-DQA2	8.39e-05	24	105	3	EFO_0004239
Disease	Rett Syndrome	GABBR2 CDKL5	1.25e-04	5	105	2	C0035372
Disease	Rett Syndrome, Atypical	GABBR2 CDKL5	1.25e-04	5	105	2	C2748910
Disease	diastolic blood pressure, systolic blood pressure	HDAC9 AOC1 HDAC4 MAP1B HLA-DOA FIGN SAMD10 LOXL1 SEC16A MMRN2	1.42e-04	670	105	10	EFO_0006335, EFO_0006336
Disease	Congenital muscular dystrophy (disorder)	LAMA2 SYNE2	1.86e-04	6	105	2	C0699743
Disease	Intellectual Disability	SOX9 NDST1 HIVEP2 TCF20 HDAC4 MAP1B UGP2 MED13	2.02e-04	447	105	8	C3714756
Disease	acute lymphoblastic leukemia (is_marker_for)	HDAC4 HDAC1 HDAC2	2.42e-04	34	105	3	DOID:9952 (is_marker_for)
Disease	Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia	HDAC4 HDAC1	2.60e-04	7	105	2	C3714844
Disease	Pulmonary Hypertension, Primary, 1	HDAC4 HDAC1	2.60e-04	7	105	2	C4552070
Disease	PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED	HDAC4 HDAC1	2.60e-04	7	105	2	C1969342
Disease	Pulmonary Hypertension, Primary, Fenfluramine-Associated	HDAC4 HDAC1	2.60e-04	7	105	2	C1969343
Disease	myocardial infarction	HDAC9 HDAC4 NDST2 LAMC1 FIGN PMEPA1 BMP1	2.62e-04	350	105	7	EFO_0000612
Disease	carpal tunnel syndrome	AOC1 HLA-DQA1 PMEPA1 LOXL1	2.93e-04	89	105	4	EFO_0004143
Disease	response to simvastatin, PCSK9 protein measurement	GABBR2 CFAP44	4.44e-04	9	105	2	EFO_0006899, GO_1903491
Disease	dysplasia of cervix	HLA-DQA1 PAX8	4.44e-04	9	105	2	EFO_1000910
Disease	alopecia areata (is_marker_for)	HDAC1 HDAC2	5.54e-04	10	105	2	DOID:986 (is_marker_for)
Disease	cervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3	HLA-DQA1 PAX8	5.54e-04	10	105	2	EFO_0001061, EFO_1000166
Disease	uveitis (implicated_via_orthology)	HLA-DQA1 HLA-DQA2	6.76e-04	11	105	2	DOID:13141 (implicated_via_orthology)
Disease	temporal arteritis	P4HA2 HLA-DQA1	8.09e-04	12	105	2	EFO_1001209
Disease	Colorectal Carcinoma	MAP1B RCN1 LAMC1 PTPRU CDKL5 MLH3 PAX8 MMRN2 CTNNB1	9.16e-04	702	105	9	C0009402
Disease	N-acetyl-isoputreanine measurement	AOC1 ADAM8	9.54e-04	13	105	2	EFO_0800107
Disease	autism spectrum disorder, schizophrenia	TCF20 HLA-DOA HLA-DQA1 HLA-DQA2 PMEPA1 ITIH4	1.14e-03	327	105	6	EFO_0003756, MONDO_0005090
Disease	total blood protein measurement	AOC1 HLA-DOA HLA-DQA1 HSPA12B PMEPA1 TLK1 SEC16A	1.14e-03	449	105	7	EFO_0004536
Disease	systemic lupus erythematosus, COVID-19	HLA-DOA HLA-DQA1 ITGAX	1.17e-03	58	105	3	MONDO_0007915, MONDO_0100096
Disease	Non-steroidal anti-inflammatory and antirheumatic product use measurement	NDST1 HLA-DQA1	1.28e-03	15	105	2	EFO_0009935
Disease	Alzheimer disease, Cognitive impairment	HDAC9 BMP1	1.28e-03	15	105	2	HP_0100543, MONDO_0004975
Disease	myopia (is_implicated_in)	P4HA2 LAMA2	1.46e-03	16	105	2	DOID:11830 (is_implicated_in)
Disease	Idiopathic pulmonary arterial hypertension	HDAC4 HDAC1	1.46e-03	16	105	2	C3203102
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	HDAC9 HNRNPUL1 PMEPA1	1.49e-03	63	105	3	EFO_0001645, EFO_0004792
Disease	pulmonary hypertension (is_marker_for)	HDAC4 HDAC1 HDAC2	1.56e-03	64	105	3	DOID:6432 (is_marker_for)
Disease	susceptibility to hepatitis B infection measurement	HLA-DOA HLA-DQA1 MINDY3	1.56e-03	64	105	3	EFO_0008405
Disease	Familial primary pulmonary hypertension	HDAC4 HDAC1	1.65e-03	17	105	2	C0340543
Disease	sclerosing cholangitis	HDAC9 HLA-DOA HLA-DQA1	1.70e-03	66	105	3	EFO_0004268
Disease	squamous cell carcinoma	HLA-DQA1 RCC2 SEC16A	1.78e-03	67	105	3	EFO_0000707
Disease	tissue plasminogen activator measurement, coronary artery disease	HDAC9 HNRNPUL1 PMEPA1	2.10e-03	71	105	3	EFO_0001645, EFO_0004791
Disease	perceived unattractiveness to mosquitos measurement	P4HA2 HLA-DQA1 MEP1A	2.19e-03	72	105	3	EFO_0008380
Disease	Craniofacial Abnormalities	SOX9 NDST1 HOXB1 CTNNB1	2.38e-03	156	105	4	C0376634
Disease	intellectual disability (implicated_via_orthology)	NDST1 HIVEP2 NDST2	2.45e-03	75	105	3	DOID:1059 (implicated_via_orthology)
Disease	Endometrioma	NR4A1 PRLR HDAC1 HDAC2	2.66e-03	161	105	4	C0269102
Disease	Endometriosis	NR4A1 PRLR HDAC1 HDAC2	2.66e-03	161	105	4	C0014175
Disease	Henoch-Schoenlein purpura	HLA-DQA1 FIGN	2.77e-03	22	105	2	EFO_1000965
Disease	female reproductive system disease	HLA-DQA1 GABBR2	3.02e-03	23	105	2	EFO_0009549
Disease	mean platelet volume	HDAC9 HIVEP2 AOC1 BTBD2 RCC2 SP8 PCYOX1L TLK1 SRPX2 SYNE2	3.48e-03	1020	105	10	EFO_0004584

Protein segments in the cluster

Peptide	Gene	Start	Entry
SQGAVPSHRSYGEDY	CATSPER1	101	Q8NEC5
GKYYSSVPEEGGATH	AKIP1	101	Q9NQ31
QSTNGTHASYGPFYL	AKTIP	61	Q9H8T0
DGGYSEDPFGVYHVN	ADPRM	281	Q3LIE5
TGQSLGYGFVNYSDP	ELAVL3	76	Q14576
FYQGHVEGYPDSAAS	ADAM8	106	P78325
ATGYVHATFYTPEGL	AOC1	481	P19801
GNFSSPEYPNGYSAH	BMP1	331	P13497
LGGYDSGFLYHCEFP	CFAP44	766	Q96MT7
SYGPSGQYTHEFDGD	HLA-DQA1	41	P01909
NGYFVHYFAPEGLTT	ITIH4	256	Q14624
GLTAVSHNGSYVYFP	NWD1	1216	Q149M9
GYYLGNPAEFHDSSD	RCN1	146	Q15293
YSFGCPEYGQLGHNS	RCC2	276	Q9P258
AGSEYSGNAYGHTPY	PAX8	396	Q06710
SGNAYGHTPYSSYSE	PAX8	401	Q06710
YGRDRDYSDHPSGGS	RBMX	266	P38159
FSHPAGLSYRYVAEG	ITGAX	821	P20702
GSFGHFSPSQTYEGL	NR4A1	156	P22736
QDDPSYRSFHSGGYG	CTNNB1	711	P35222
YRSFHSGGYGQDALG	CTNNB1	716	P35222
APGYNGSYLHSTYSS	FIGN	186	Q5HY92
VASYGVNFYQSHGPS	HLA-DQA2	31	P01906
DQGSSGPESFTVYHY	MINDY3	371	Q9H8M7
FAGGVVSPQPHSSYY	KIDINS220	1111	Q9ULH0
YVAGLPRFTYGHAGT	KLHL36	426	Q8N4N3
SLHRYDDGNFFPGSG	HDAC4	861	P56524
LEDFYGVFSSPGYTH	LRP10	196	Q7Z4F1
DGGHTLGDPSYSYET	MAP1B	1996	P46821
PYQSSAATSGGAGHY	MALT1	736	Q9UDY8
LSAGHRDVFYYSPSG	MBD3	26	O95983
VSFHKYGEYFPGTGD	HDAC1	196	Q13547
TVGTPYKGGNLYHTD	GOLGA4	2151	Q13439
TTYINIGSSYFPEHG	MMRN2	846	Q9H8L6
FDGDYGALFQSHSYP	LRFN1	706	Q9P244
HSLYSEGTPGFEQAY	LOXL1	276	Q08397
GTSGGAYDHSYVELF	HNRNPH2	366	P55795
LVHGYLNSSYFGFPD	PCYOX1L	336	Q8NBM8
NDAFLYIYESGGPGH	MLH3	436	Q9UHC1
SLAADYGFPDVGHLY	PCDH1	76	Q08174
EHRYYGESLPFGDNS	PRCP	121	P42785
HTIFYNEYPGGSSEL	NDST1	491	P52848
HGPGLETIFYSSYVF	MFSD2B	406	A6NFX1
GLPYFSYDLGSGDTH	LAMA2	2821	P24043
QGDIFSVGSGSPYAY	PSMB11	171	A5LHX3
PEGAFHSFGYTARDY	HSPA12B	111	Q96MM6
FGSNLTGHGYPDASY	DTX1	586	Q86Y01
TYSEVIGHYPGSSFQ	PMEPA1	231	Q969W9
QFSYFLYSRDGHSPG	PTPRU	101	Q92729
YGVGGQYEPHFDFSR	P4HA2	421	O15460
ETYRCFGSFHGSPYE	KIR2DL4	191	Q99706
VHNYPDYVSSGGGFG	CPT1C	696	Q8TCG5
LGQSEGDGGYFHPSS	HOXB1	101	P14653
LGASYGVPSYHGNTR	CD101	471	Q93033
PAFYQSYGASGQFTH	HLA-DOA	36	P06340
HPGYALEYGGDTGSE	CPHXL2	196	A0A1W2PPK0
LEYGGDTGSEHSTAY	CPHXL2	201	A0A1W2PPK0
TSFDIHYGSGSLSGY	CTSD	136	P07339
SPSQGGYFGPDLYSH	BTBD7	966	Q9P203
GYFGPDLYSHNKASP	BTBD7	971	Q9P203
YLSGGSSIPEGHCYA	HRH3	176	Q9Y5N1
HTSVGGLGDSFYEYL	MAN1A2	391	O60476
RSGVGPSKFHGYAYD	GABBR2	346	O75899
GVGPGNYSFSYQLED	EPOR	71	P19235
SHSAFGYNGELYIFG	KLHDC3	241	Q9BQ90
CYFDPELYRSTGHGG	LAMC1	351	P11047
EIGPVSSSRFGHYYD	ELP4	171	Q96EB1
SLHRYDEGNFFPGSG	HDAC9	841	Q9UKV0
TVSFHKYGEYFPGTG	HDAC2	196	Q92769
FGLYGSIHGPTDYQV	BTBD2	406	Q9BX70
SAPHESFSYGLGYTS	CDKL5	586	O76039
YYGHGANSPISTDLF	SLC39A10	346	Q9ULF5
DGYSRHYEDGYPGGS	CTNND1	211	O60716
GYSGPDGHYAMDNIT	HNRNPUL1	91	Q9BUJ2
FHYNDTAGYFIIGGS	SEL1L3	391	Q68CR1
SSGSSGYQDYYPHGR	RHBDD1	236	Q8TEB9
YGRDRDYSDHPSGGS	RBMXL1	266	Q96E39
GHSYQGAPFYQFSST	TBR1	181	Q16650
GGSSSHEEDEEGPYY	SYNE2	6426	Q8WXH0
YGINFSPNGYHIATG	PRPF4	411	O43172
YLGTYGLHSSEGPFT	PRR5	211	P85299
NSEGYGFGVTLYPNS	MEP1A	461	Q16819
GTDTPQGRLYSDHYG	SAMD10	86	Q9BYL1
KHGQGTFIYPDGSRY	RSPH1	76	Q8WYR4
VPATHGQVTYTGSYG	SOX9	306	P48436
TGDYLFEPHSGEEYT	SRPK1	546	Q96SB4
EYGTAYTPQTHTSFG	MED13	971	Q9UHV7
SPLGGYNSDYSGLSH	SP8	246	Q8IXZ3
AYFSPYNGGSLGHDE	ABTB2	301	Q8N961
IVSGYGHYLTFDGFP	TECTA	1101	O75443
DPSLLHGEGGYYLTS	RIN2	726	Q8WYP3
ISDYFEYQGGNGSSP	TLK1	146	Q9UKI8
PGHGDIYASFYNSGL	UGP2	221	Q16851
PQAAEGHYTVSYGTD	SPART	176	Q8N0X7
GHYTVSYGTDSGEFS	SPART	181	Q8N0X7
HGSIVGAYAGYPSQF	ZNF703	316	Q9H7S9
YGFDSYGPVTDSLIH	ZNF460	151	Q14592
YDIPFTQRGHISGSY	ZC3H6	106	P61129
GSGIYAPNSSRAFHY	VNN1	276	O95497
PGSFHGDFAYGTYRS	SEC16A	1396	O15027
DGEATCYSPKGGNYH	SRPX2	66	O60687
AAHGTGVYTGPEFYT	STYXL2	166	Q5VZP5
GTDGGLPTNYSLTYH	PRLR	51	P16471
YLGDAFGSPQTDHGF	ZNF395	241	Q9H8N7
GLFTHTIFYNEYPGG	NDST2	486	P52849
HYQQDYTGPFSPGSA	TCF20	151	Q9UGU0
VYSSHTGYPGGFRQV	MRPL13	76	Q9BYD1
DTAIYSDISGGGHPY	TMEM245	791	Q9H330
ATAAAYGGYPTAHTA	ZFR	101	Q96KR1
LYGDQEGAYEHPGSS	HIVEP2	2186	P31629
VHITGFGALYYGGES	TMPRSS11A	306	Q6ZMR5
GTGFLEETSLFYGHY	TMC7	236	Q7Z402
HGEGTLYFPSGSQYD	MORN5	41	Q5VZ52
HDDSYTATGYGRAPG	JUNB	11	P17275
SNGPGFYLYDLGSTH	SLC4A1AP	226	Q9BWU0